https://www.pharmaceutical-business-review.com/news/mallinckrodt-biovectra/ 2019-09-12T08:10:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Baxter.jpg https://www.pharmaceutical-business-review.com/news/hansoh-pharma-atomwise-launch-ai-drug-discovery-collaboration-for-multiple-therapeutic-areas/ 2019-09-12T10:21:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Phar.jpg https://www.pharmaceutical-business-review.com/news/vbi-vaccines-announces-phase-2a-trial-of-vbi-1901-cancer-vaccine-candidate-in-combination-with-as01b-adjuvant-system-in-recurrent-glioblastoma-patients/ 2019-09-12T10:49:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/blood-20745_960_720.jpg https://www.pharmaceutical-business-review.com/news/aytu-bioscience-to-acquire-innovus-pharmaceuticals/ 2019-09-13T09:02:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/pharacq.jpg https://www.pharmaceutical-business-review.com/news/celgenes-quazar-aml-001-trial-of-cc-486-meets-primary-and-key-secondary-endpoints/ 2019-09-13T10:49:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/cel-cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/ctd-holdings-announces-fda-approval-of-us-expanded-access-treatment-program-in-niemann-pick-disease-type-c/ 2019-09-16T10:16:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/fda-gsk-nucala-asthma/ 2019-09-16T10:35:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/gsk-house.jpg https://www.pharmaceutical-business-review.com/news/roches-tecentriq-lung-cancer-2/ 2019-09-16T10:35:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Roche-1-1.jpg https://www.pharmaceutical-business-review.com/news/arrowhead-presents-initial-top-line-clinical-data-and-preclinical-data-on-rnai-candidates-aro-apoc3-and-aro-ang3/ 2019-09-16T10:43:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/science-1336663_960_720.jpg https://www.pharmaceutical-business-review.com/news/lundbeck-alder-biopharmaceuticals/ 2019-09-17T07:56:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Lundbeck.jpg https://www.pharmaceutical-business-review.com/news/accenture-announces-collaboration-with-bayer-to-streamline-drug-development-processes-through-intient-clinical-platform/ 2019-09-17T07:56:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/drug.jpg https://www.pharmaceutical-business-review.com/news/aimmune-peanut-allergy-drug-fda/ 2019-09-17T08:03:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/aim-nuts-1736520_960_720.jpg https://www.pharmaceutical-business-review.com/news/novartis-rms-ofatumumab/ 2019-09-17T08:03:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Novartistower.jpg https://www.pharmaceutical-business-review.com/news/alnylam-initiates-apollo-b-phase-3-study-of-patisiran-for-treatment-of-transthyretin-amyloidosis-with-cardiomyopathy/ 2019-09-17T10:17:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/aln-science-1029385_960_720.jpg https://www.pharmaceutical-business-review.com/news/poxel-initiates-phase-1b-multiple-ascending-dose-trial-for-nash-drug-candidate/ 2019-09-18T08:07:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Poxel.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-fda-heart-failure/ 2019-09-18T09:28:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/concert-pharmaceuticals-completes-enrollment-in-second-open-label-trial-of-ctp-543-in-alopecia-areata/ 2019-09-18T10:48:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/test-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/fkeytruda-lenvima-endometrial-carcinoma/ 2019-09-19T07:55:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/graybug-vision-initiates-clinical-trial-in-macular-edema-secondary-to-diabetic-macular-edema-or-retinal-vein-occlusion/ 2019-09-19T08:19:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/retina.jpg https://www.pharmaceutical-business-review.com/news/ironwood-pharmaceuticals-and-astrazeneca-amend-linzess-linaclotide-collaboration-in-china/ 2019-09-19T10:41:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-prevent-trial/ 2019-09-19T23:57:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/novartis-tower-with-logo-image.jpg https://www.pharmaceutical-business-review.com/news/sanbio-rmat-sb623-cell-therapy/ 2019-09-20T00:01:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/roche-gazyva-lupus-nephritis/ 2019-09-20T00:04:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Rochebuilding.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-to-treat-fatty-acid-oxidation-disorders/ 2019-09-23T10:38:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/pharm.jpg https://www.pharmaceutical-business-review.com/news/chmp-adopts-positive-opinion-for-bavencio-plus-axitinib-for-advanced-renal-cell-carcinoma/ 2019-09-23T11:27:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Pfizerworld-2.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-inflammasome/ 2019-09-24T08:04:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/800px-Siedziba_Boehringer_Ingelheim_w_Polsce.jpg https://www.pharmaceutical-business-review.com/news/pifeltro-delstrigo-hiv-1/ 2019-09-24T08:04:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/clovis-oncology-acquires-rights-to-fap-targeted-radiopharmaceutical-programme-from-3b-pharmaceuticals/ 2019-09-24T09:54:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Clovis.jpg https://www.pharmaceutical-business-review.com/news/ipsen-announces-positive-results-from-engage-study-of-dysport-combo-with-gsc-in-adults-with-upper-and-lower-limb-spastic-hemiparesis/ 2019-09-24T10:31:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/ipsen-science-1336663_960_720.jpg https://www.pharmaceutical-business-review.com/news/cerevels-tavapadon-phase-2-trial/ 2019-09-25T07:49:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/cere-laboratory-3827743_960_720.jpg https://www.pharmaceutical-business-review.com/news/annexons-guillain-barre-syndrome/ 2019-09-25T07:50:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDAdrug-4.jpg https://www.pharmaceutical-business-review.com/news/aldeyra-therapeutics-receives-fast-track-designation-for-adx-2191-for-prevention-of-proliferative-vitreoretinopathy/ 2019-09-25T08:05:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDAdrug-5.jpg https://www.pharmaceutical-business-review.com/news/amphivena-closes-62m-series-c-financing-to-expand-clinical-development-of-amv564-into-solid-tumors-and-to-develop-t-cell-engagement-portfolio/ 2019-09-25T10:54:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/tip-agreement-3489902_960_720.jpg https://www.pharmaceutical-business-review.com/news/pfizer-flatiron-health-collaboration/ 2019-09-26T08:06:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/zealands-pharma-dasiglucagon/ 2019-09-26T08:06:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/autoinjector.jpg https://www.pharmaceutical-business-review.com/news/blade-therapeutics-expands-anti-fibrotic-pipeline-with-acquisition-of-atxco-and-its-autotaxin-inhibitor/ 2019-09-26T09:49:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Autoxin.jpg https://www.pharmaceutical-business-review.com/news/incyte-announces-first-patient-treated-in-phase-3-trial-program-evaluating-ruxolitinib-cream-in-patients-with-vitiligo/ 2019-09-26T10:39:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/incy-laboratory-3827743_960_720.jpg https://www.pharmaceutical-business-review.com/news/noveome-biotherapeutics-initiates-trial-evaluating-intranasal-delivery-of-st266-targeting-optic-nerve-and-brain/ 2019-09-27T08:34:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/braincandid.png https://www.pharmaceutical-business-review.com/news/samsung-bioepis-announces-phase-3-results-of-sb8-bevacizumab-biosimilar-candidate-at-esmo-2019-congress/ 2019-09-27T11:15:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/samsung-mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/ipsen-dysport-spasticity-children/ 2019-09-30T08:19:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDAdrug-6.jpg https://www.pharmaceutical-business-review.com/news/jazzs-jzp-258-narcolepsy-trial/ 2019-09-30T08:20:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Jazz.jpg https://www.pharmaceutical-business-review.com/news/tagrisso-is-only-first-line-treatment-for-egfr-mutated-nsclc-to-deliver-median-overall-survival-of-over-three-years/ 2019-09-30T08:47:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Astra.jpg https://www.pharmaceutical-business-review.com/news/clover-biopharmaceuticals-doses-first-patient-in-phase-i-study-of-scb-313-in-china-for-malignant-ascites/ 2019-09-30T11:34:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/clover-lab-3498584_960_720.jpg https://www.pharmaceutical-business-review.com/news/gsks-niraparib-prima-trial/ 2019-10-01T08:10:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/22720111227_77ea5a925e_z.jpg https://www.pharmaceutical-business-review.com/news/roche-rituxan-blood-vessel/ 2019-10-01T08:10:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Rochebuild.jpg https://www.pharmaceutical-business-review.com/news/celltrion-to-launch-temixys-double-combination-once-daily-tablet-for-hiv-treatment-in-us/ 2019-10-01T09:33:19+00:00 https://www.pharmaceutical-business-review.com/news/restore-imi-2-phase-3-study-of-mercks-recarbrio-in-habp-vabp-meets-primary-endpoint/ 2019-10-01T11:32:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/msd-test-tubes-1-1494460.jpg https://www.pharmaceutical-business-review.com/news/servier-pixuvri-cti-biopharma/ 2019-10-02T00:22:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/red-blood-cell-4256710_960_720.jpg https://www.pharmaceutical-business-review.com/news/sobi-dova-pharmaceuticals/ 2019-10-02T05:02:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Sobi.jpg https://www.pharmaceutical-business-review.com/news/mercks-keytruda-approved-as-monotherapy-in-china-for-first-line-treatment-of-certain-patients-with-advanced-nsclc/ 2019-10-03T09:51:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/elicio-therapeutics-completes-33m-series-b-financing/ 2019-10-03T10:35:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/q2-business-3167295_960_720.jpg https://www.pharmaceutical-business-review.com/news/gilead-hiv-prep-drug-descovy/ 2019-10-04T07:40:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/HIV-drug.jpg https://www.pharmaceutical-business-review.com/news/gsk-trelegy-ellipta-asthma/ 2019-10-04T07:44:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/800px-GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg https://www.pharmaceutical-business-review.com/news/lantheus-progenics-pharmaceuticals/ 2019-10-04T07:44:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Lantheus.jpg https://www.pharmaceutical-business-review.com/news/goldfinch-bio-takeda-sign-deal-for-cb1-monoclonal-antibody-to-treat-rare-and-metabolic-kidney-diseases/ 2019-10-04T07:58:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Takeda.jpg https://www.pharmaceutical-business-review.com/news/icosavax-launches-with-51m-series-a-financing-to-advance-computationally-designed-vlp-vaccines/ 2019-10-04T08:32:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/tokio-business-3141342_960_720.jpg https://www.pharmaceutical-business-review.com/news/dbv-technologies-announces-fda-acceptance-of-bla-filing-for-viaskin-peanut-to-treat-peanut-allergy/ 2019-10-07T09:29:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/fasenra-approved-in-the-us-for-self-administration-in-a-new-pre-filled-auto-injector-the-fasenra-pen/ 2019-10-07T11:21:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/pfenex-pf708-osteoporosis/ 2019-10-09T10:13:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-invest-500m-to-end-hiv-and-tuberculosis/ 2019-10-09T10:13:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/JJbuilding.jpg https://www.pharmaceutical-business-review.com/news/hoth-therapeutics-completes-phase-1-of-in-life-dose-escalation-study-for-treating-eczema/ 2019-10-09T11:25:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/hoth-science-1336663_960_720.jpg https://www.pharmaceutical-business-review.com/news/ideaya-announces-first-patient-dosing-of-ide196-for-solid-tumors-outside-of-uveal-melanoma/ 2019-10-09T11:32:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/ide-mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/nsf-international-amarex-cro/ 2019-10-10T08:08:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/CRO.jpg https://www.pharmaceutical-business-review.com/news/novartis-beovu-wet-amd-fda/ 2019-10-10T08:08:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/beovu.jpg https://www.pharmaceutical-business-review.com/news/dermira-begins-phase-3-programme-to-assess-lebrikizumab-in-patients-with-moderate-to-severe-atopic-dermatitis/ 2019-10-10T09:16:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/derma.jpg https://www.pharmaceutical-business-review.com/news/ionis-factor-xi-anti-thrombotic-medicine-advances-with-bayer-following-positive-clinical-results/ 2019-10-10T10:05:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/red-blood-cell-4216070_960_720.jpg https://www.pharmaceutical-business-review.com/news/akcea-to-license-investigative-antisense-therapy-akcea-angptl3-lrx-to-pfizer/ 2019-10-10T10:48:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/alexion-stealth-announce-agreement-for-option-to-co-develop-and-commercialise-late-stage-therapy-for-mitochondrial-diseases/ 2019-10-11T09:31:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/mitochondria.jpg https://www.pharmaceutical-business-review.com/news/gilead-galapagos-announce-52-week-results-of-filgotinib-in-finch-1-finch-3-studies-in-rheumatoid-arthritis/ 2019-10-11T10:49:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/gil-test-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/viela-mitsubishi-tanabe-inebilizumab/ 2019-10-14T08:09:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/800px-Mitsubishi_Tanabe_Pharma.jpg https://www.pharmaceutical-business-review.com/news/sun-pharma-launches-cequa-for-treatment-of-dry-eye-disease-in-us/ 2019-10-14T09:11:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/dry-eye.jpg https://www.pharmaceutical-business-review.com/news/pfizer-presents-positive-phase-3-data-for-abrocitinib-in-moderate-to-severe-atopic-dermatitis/ 2019-10-14T10:27:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/mabthera-pemphix-trial-pemphigus-vulgaris/ 2019-10-14T13:12:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/roche-location.jpg https://www.pharmaceutical-business-review.com/news/ucb-ra-pharmaceuticals/ 2019-10-14T13:17:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/UCB.jpg https://www.pharmaceutical-business-review.com/news/forbius-completes-enrollment-into-phase-1a-solid-tumour-trial-of-avid200/ 2019-10-15T09:19:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/tumor.jpg https://www.pharmaceutical-business-review.com/news/kyowa-kirin-launches-nourianz-in-us-for-treatment-of-parkinsons-disease-off-episodes/ 2019-10-15T11:00:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/thermometer-1539191_960_720.jpg https://www.pharmaceutical-business-review.com/news/thermo-fisher-ionicx-xrf-analyzer/ 2019-10-15T13:22:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Newsroom-Photos-Company-1.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-migraine-reyvow/ 2019-10-15T13:23:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Lilli.jpg https://www.pharmaceutical-business-review.com/news/sun-pharma-launches-drizalma-sprinkle-in-us/ 2019-10-16T09:38:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/capsule.jpg https://www.pharmaceutical-business-review.com/news/trialbee-and-trinetx-partner-to-accelerate-patient-centric-clinical-trials/ 2019-10-16T10:13:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/hospital-3089884_960_720.jpg https://www.pharmaceutical-business-review.com/news/crispr-ksq-therapeutics-cell-therapies/ 2019-10-16T12:42:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/ksq-dna-1903318_960_720.jpg https://www.pharmaceutical-business-review.com/news/janssen-bayer-xarelto-vte/ 2019-10-16T12:43:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Bayer_Berlin.jpg https://www.pharmaceutical-business-review.com/news/tripharm-services-announces-creation-of-pharmaceutical-manufacturing-center/ 2019-10-17T09:32:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/TRipharm.jpg https://www.pharmaceutical-business-review.com/news/acino-takeda-prescription-pharmaceutical/ 2019-10-17T10:49:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Takeda-build.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-enrols-first-patient-in-phase-ii-balance-cftm-1-study/ 2019-10-17T10:51:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/medic-563423_6401.jpg https://www.pharmaceutical-business-review.com/news/alexion-biopharmaceutical-firm-achillion/ 2019-10-18T08:03:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Alexion.jpg https://www.pharmaceutical-business-review.com/news/trastuzumab-deruxtecan-granted-fda-priority-review-to-treat-patients-with-her2-positive-metastatic-breast-cancer/ 2019-10-18T10:29:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Astra.jpg https://www.pharmaceutical-business-review.com/news/horizon-therapeutics-initiates-protect-clinical-trial-of-krystexxa-pegloticase-injection/ 2019-10-18T11:54:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/test-214185_640.jpg https://www.pharmaceutical-business-review.com/news/verseau-launches-with-50m-to-develop-first-in-class-macrophage-targeted-immunotherapies/ 2019-10-21T10:57:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/rop-agreement-3489902_960_720.jpg https://www.pharmaceutical-business-review.com/news/deals/sartorius-stedim-danaher-deal/ 2019-10-21T12:13:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/rop-agreement-3489902_960_720-1.jpg https://www.pharmaceutical-business-review.com/news/fda-roche-xofluza-flu/ 2019-10-21T12:13:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Rochebuild.jpg https://www.pharmaceutical-business-review.com/news/odonate-therapeutics-announces-completion-of-enrollment-in-contessa-metastatic-breast-cancer-trial/ 2019-10-22T09:37:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Meta.jpg https://www.pharmaceutical-business-review.com/news/alexion-receives-fda-approval-for-ultomiris-for-atypical-hemolytic-uremic-syndrome/ 2019-10-22T10:26:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-trikafta-to-treat-the-underlying-cause-of-cystic-fibrosis/ 2019-10-22T11:06:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/knibusiness-3167295_960_720-1.jpg https://www.pharmaceutical-business-review.com/news/deals/knight-therapeutics-acquire-biotoscana/ 2019-10-22T11:17:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/knibusiness-3167295_960_720.jpg https://www.pharmaceutical-business-review.com/news/bavarian-nordic-gsk/ 2019-10-22T11:17:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/gsk-house.jpg https://www.pharmaceutical-business-review.com/news/zealand-pharma-expands-peptide-platform-with-acquisition-of-encycle-therapeutics/ 2019-10-23T09:32:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Zealand.jpg https://www.pharmaceutical-business-review.com/news/cyclo-therapeutics-completes-enrollment-in-phase-1-trial-to-evaluate-trappsol-cyclo-for-the-treatment-of-niemann-pick-disease-type-c/ 2019-10-23T10:58:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/cyclotest-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-heart-failure/ 2019-10-23T12:53:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Astra-1.jpg https://www.pharmaceutical-business-review.com/news/moderna-propionic-acidemia/ 2019-10-24T07:13:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/talaris-therapeutics-initiates-phase-3-clinical-trial-of-fcr001-in-living-donor-kidney-transplant-recipients/ 2019-10-24T09:28:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Humankidney.jpg https://www.pharmaceutical-business-review.com/news/rapt-therapeutics-announces-initiation-of-first-in-human-phase-1-study-of-rpt193/ 2019-10-24T10:47:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/rscience-1336663_960_720.jpg https://www.pharmaceutical-business-review.com/news/takeda-tak-101-license-cour/ 2019-10-25T07:46:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/800px-Takeda_Pharmaceutical_Company_Tokyo_Head_Office_1.jpg https://www.pharmaceutical-business-review.com/news/avrobio-receives-orphan-drug-designation-from-fda-for-avr-rd-02-to-treat-gaucher-disease/ 2019-10-25T09:37:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/spectrum-pharmaceuticals-announces-submission-to-fda-of-updated-bla-for-rolontis/ 2019-10-25T10:25:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/lipac-oncology-announces-successful-completion-of-phase-1-bladder-cancer-clinical-study-and-initiation-of-phase-2a-study/ 2019-10-28T10:58:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/lipac-cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/macrogenics-announces-initiation-of-phase-2-3-mahogany-study-of-margetuximab-in-gastric-or-gastroesophageal-junction-cancer/ 2019-10-28T11:04:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/macscience-1336663_960_720.jpg https://www.pharmaceutical-business-review.com/news/imfinzi-and-imfinzi-plus-tremelimumab-delayed-disease-progression-in-poseidon-trial/ 2019-10-29T09:25:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/gilead-and-glympse-bio-announce-strategic-collaboration-for-use-of-biomarker-technology-in-nash-clinical-development/ 2019-10-29T09:31:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Hepatitis.png https://www.pharmaceutical-business-review.com/news/gsk-ovarian-cancer-zejula/ 2019-10-29T10:06:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/GSK.jpg https://www.pharmaceutical-business-review.com/news/bms-melanoma-drug-opdivo/ 2019-10-29T10:07:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/BMSfacility.jpg https://www.pharmaceutical-business-review.com/news/gsk-phase-3-program-gepotidacin/ 2019-10-29T10:19:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/gsk-house-location-building.jpg https://www.pharmaceutical-business-review.com/news/astellas-gilteritinib-ec-approval-aml/ 2019-10-29T10:19:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/asmitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/femtogenix-presents-data-on-antibody-drug-conjugates-containing-reduced-potency-payloads-in-solid-tumour-models/ 2019-10-30T09:17:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/virus.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-advances-first-pan-kras-inhibitor-bi-1701963-into-clinical-testing/ 2019-10-30T10:38:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/800px-Siedziba_Boehringer_Ingelheim_w_Polsce-1.jpg https://www.pharmaceutical-business-review.com/news/pfizer-bavencio-axitinib/ 2019-10-30T11:37:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/acadia-pharmaceuticals-initiates-phase-3-pivotal-study-of-trofinetide-in-rett-syndrome/ 2019-10-31T10:08:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/acscience-1336663_960_720.jpg https://www.pharmaceutical-business-review.com/news/roches-marketing-applications-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-accepted-for-review-by-ema-and-fda/ 2019-10-31T10:09:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Roche.jpg https://www.pharmaceutical-business-review.com/news/themis-mv-lasv-lassa-fever-vaccine/ 2019-10-31T10:13:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/syringe-417786_960_720.jpg https://www.pharmaceutical-business-review.com/news/terns-fxr-agonist-nash/ 2019-10-31T12:57:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/FDAdrug-4.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-europe-russia-cheplapharm/ 2019-11-01T07:48:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Russia.jpg https://www.pharmaceutical-business-review.com/news/cycle-pharmaceuticals-and-catalent-partner-to-develop-treatments-for-rare-diseases-using-zydis-odt-technology/ 2019-11-01T09:33:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Zydis.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-initiates-clinical-trial-of-ds-7300-in-collaboration-with-sarah-cannon-research-institute/ 2019-11-01T10:57:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/dtest-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/pandion-astellas-pancreas-immunomodulators/ 2019-11-04T07:40:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/plab-3498584_960_720.jpg https://www.pharmaceutical-business-review.com/news/amgen-enters-into-strategic-collaboration-with-beigene-to-expand-oncology-presence-in-china/ 2019-11-04T10:18:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Amgenhead.jpg https://www.pharmaceutical-business-review.com/news/biocryst-begins-phase-1-trial-with-bcx9250-for-treatment-of-fibrodysplasia-ossificans-progressiva/ 2019-11-04T10:27:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/blab-3498584_960_720.jpg https://www.pharmaceutical-business-review.com/news/samsung-biologics-and-ichnos-sciences-announce-agreement-for-manufacture-of-isb-830/ 2019-11-05T11:05:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/sams.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-and-lilly-modernise-alliance-to-focus-full-expertise-on-jardiance/ 2019-11-05T11:10:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Eli-lilly.jpg https://www.pharmaceutical-business-review.com/news/roche-dicerna-hbv-infection/ 2019-11-05T13:04:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Basel.jpg https://www.pharmaceutical-business-review.com/news/sanofis-fluzone-vaccine-quadrivalent/ 2019-11-05T13:17:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/18427615004_ceee61fd8a_b.jpg https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-exceed-trial/ 2019-11-05T13:17:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/novartis-tower-with-logo-image.jpg https://www.pharmaceutical-business-review.com/news/redhill-talicia-h-pylori-infection/ 2019-11-06T03:57:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/800px-FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/japans-takeda-opens-dengue-vaccine-manufacturing-facility-in-germany/ 2019-11-06T08:29:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Singen.jpg https://www.pharmaceutical-business-review.com/news/halozyme-pegph20-halo-301-trial/ 2019-11-06T08:49:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/hlaboratory-3827745_960_720.jpg https://www.pharmaceutical-business-review.com/news/sandoz-pegfilgrastim-biosimilar-ziextenzo/ 2019-11-06T08:50:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/tower-with-logo-through-branches-image1-e1573022203998.jpg https://www.pharmaceutical-business-review.com/news/a2-biotherapeutics-emerges-from-stealth-mode-to-develop-tumour-cell-therapeutics/ 2019-11-06T09:05:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/therapy.jpg https://www.pharmaceutical-business-review.com/news/cyclica-collaborates-with-enamine-to-use-real-technology-in-its-ligand-design-platform-for-ai-augmented-drug-design/ 2019-11-06T10:38:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/cyartificial-intelligence-3382507_960_720.jpg https://www.pharmaceutical-business-review.com/news/axcella-achieves-initial-milestones-with-its-hematology-product-candidate-axa4010/ 2019-11-07T09:52:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/bloodhemo.jpg https://www.pharmaceutical-business-review.com/news/samsung-bioepis-enters-into-commercialisation-agreement-for-next-generation-biosimilar-candidates/ 2019-11-07T10:57:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/sabusiness-3152586_960_720.jpg https://www.pharmaceutical-business-review.com/news/takedas-dengue-vaccine-candidate-demonstrates-protection-in-children-ages-four-to-16-years/ 2019-11-08T09:11:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Takeda.jpg https://www.pharmaceutical-business-review.com/news/roxadustat-significantly-increased-hemoglobin-levels-for-chronic-kidney-disease-patients-with-anemia-in-phase-iii-olympus-and-rockies-trials/ 2019-11-08T11:32:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Astra-1.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-ebola-vaccine/ 2019-11-11T07:36:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/JandJ.jpg https://www.pharmaceutical-business-review.com/news/regeneron-vyriad-oncolytic-virus/ 2019-11-11T07:36:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Regeneron.jpg https://www.pharmaceutical-business-review.com/news/abbvie-submits-snda-to-fda-for-imbruvica-rituximab-combo-for-cll/ 2019-11-11T11:16:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/AbbVieHQ.jpg https://www.pharmaceutical-business-review.com/news/stone-capital-partners-biosyngen-to-setup-50m-biopharmaceutical-investment-fund-in-singapore/ 2019-11-11T11:20:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/shen.jpg https://www.pharmaceutical-business-review.com/news/atai-life-sciences-and-cyclica-launch-joint-venture-to-revolutionise-drug-development-for-mental-health-disorders/ 2019-11-12T09:00:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Mental.jpg https://www.pharmaceutical-business-review.com/news/novartis-sandoz-aspen/ 2019-11-12T09:53:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Novartis.jpg https://www.pharmaceutical-business-review.com/news/nec-and-vaximm-announce-collaboration-to-advance-personalized-neoantigen-cancer-vaccines/ 2019-11-12T11:47:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/laboratory-3827745_640.jpg https://www.pharmaceutical-business-review.com/news/fda-reblozyl-anaemia-beta-thalassemia/ 2019-11-12T13:00:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/blood-1813410_1280.jpg https://www.pharmaceutical-business-review.com/news/x4-pharmaceuticals-receives-breakthrough-therapy-designation-from-fda-for-mavorixafor-to-treat-whim-syndrome/ 2019-11-13T09:02:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/mylan-pfizer-announce-viatris-as-new-company-name/ 2019-11-13T11:25:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/lupin-sell-kyowa-unison/ 2019-11-13T11:38:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/vinita-gupta.jpg https://www.pharmaceutical-business-review.com/news/roches-risdiplam-sunfish-trial/ 2019-11-13T11:38:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/roche-location.jpg https://www.pharmaceutical-business-review.com/news/rdd-pharma-signs-loi-to-acquire-naia-rare-diseases/ 2019-11-14T09:44:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/RDI.jpg https://www.pharmaceutical-business-review.com/news/finch-therapeutics-takeda-expand-collaboration-to-develop-microbiome-therapeutics/ 2019-11-14T10:16:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/agreement-3489902_6401.jpg https://www.pharmaceutical-business-review.com/news/gsks-mepolizumab-phase-3-trial/ 2019-11-14T12:14:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Glaxo_Smith_Kline_Offices_on_the_Great_West_Road_at_Brentford_-_panoramio.jpg https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-jardiance/ 2019-11-14T12:14:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Lilli.jpg https://www.pharmaceutical-business-review.com/news/merck-calporta-therapeutics/ 2019-11-15T08:20:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Merck.jpg https://www.pharmaceutical-business-review.com/news/epicentrx-closes-35m-series-d-financing-to-support-development-of-small-molecule-immunotherapy-and-oncolytic-viral-platform/ 2019-11-15T09:30:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Virus.jpg https://www.pharmaceutical-business-review.com/news/us-fda-accepts-regulatory-submission-for-selumetinib/ 2019-11-15T12:25:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/original.jpg https://www.pharmaceutical-business-review.com/news/roche-promedior-biotechnology/ 2019-11-18T07:30:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Basel-1.jpg https://www.pharmaceutical-business-review.com/news/qtrilmet-approved-in-eu-to-treat-type-2-diabetes/ 2019-11-18T09:18:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/medicinetab.jpg https://www.pharmaceutical-business-review.com/news/the-medicines-company-announces-that-the-orion-10-study-of-inclisiran-showed-durable-and-potent-lowering-of-ldl-c/ 2019-11-18T10:28:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/test-214185_640.jpg https://www.pharmaceutical-business-review.com/news/shionogi-cuti-drug-fetroja/ 2019-11-18T12:37:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/alkermes-rodin-therapeutics/ 2019-11-19T08:03:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Rodin.jpg https://www.pharmaceutical-business-review.com/news/aerie-pharmaceuticals-agrees-to-acquire-avizorex-pharma/ 2019-11-19T09:29:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/pharma.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-pfizers-biosimilar-abrilada-adalimumab-afzb-for-multiple-inflammatory-conditions/ 2019-11-19T10:39:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/cns-pharmaceuticals-acquired-worldwide-rights-for-brain-cancer-drug-from-houston-pharmaceuticals/ 2019-11-20T08:27:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/drug.jpg https://www.pharmaceutical-business-review.com/news/sangamo-announces-uk-authorisation-of-a-phase-1-2-clinical-trial-evaluating-the-car-treg-cell-therapy-tx200-for-kidney-transplantation/ 2019-11-20T10:14:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/test-214185_6401.jpg https://www.pharmaceutical-business-review.com/news/newron-sarizotan-rett-syndrome/ 2019-11-20T11:35:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/dicerna-novo-nordisk-rnai-deal/ 2019-11-20T11:35:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/NOVO_NORDISK_HQ-exterior-far-lowres2.jpg https://www.pharmaceutical-business-review.com/news/janssen-darzalex-multiple-myeloma/ 2019-11-21T08:06:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Johnson.jpg https://www.pharmaceutical-business-review.com/news/alnylam-announces-approval-of-givlaari-by-us-fda/ 2019-11-21T09:02:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Gilvari.jpg https://www.pharmaceutical-business-review.com/news/ec-approves-two-new-regimens-of-mercks-keytruda-for-metastatic-or-unresectable-recurrent-hnscc/ 2019-11-21T10:33:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-celgene/ 2019-11-22T07:54:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Pomalyst.jpg https://www.pharmaceutical-business-review.com/news/vor-biopharma-and-maxcyte-announce-clinical-and-commercial-licence-agreement-for-engineered-hematopoietic-stem-cells-to-treat-cancer/ 2019-11-22T11:25:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/cancer.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-nih-collaborate-on-investigational-bnab-for-hiv-treatment/ 2019-11-22T11:31:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/gsk-house-location-building.jpg https://www.pharmaceutical-business-review.com/news/novartis-adakveo-fda-sickle-cell/ 2019-11-25T06:28:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/novartis-tower-with-logo-image-1.jpg https://www.pharmaceutical-business-review.com/news/soliris-receives-approval-in-japan-for-the-prevention-of-relapse-in-patients-with-neuromyelitis-optica-spectrum-disorder/ 2019-11-25T11:22:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/laboratory-3827745_6401.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-designation-to-usona-institutes-psilocybin-for-major-depressive-disorder/ 2019-11-25T11:26:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/roche-tecentriq-avastin-imbrave150/ 2019-11-25T12:54:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/roche-location-1.jpg https://www.pharmaceutical-business-review.com/news/fda-astrazeneca-calquence/ 2019-11-25T12:54:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Astra-1.jpg https://www.pharmaceutical-business-review.com/news/epicentrx-announces-positive-results-from-phase-1-trial-of-rrx-001-as-first-line-treatment-in-newly-diagnosed-glioblastoma/ 2019-11-26T09:34:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/test-214185_6402.jpg https://www.pharmaceutical-business-review.com/news/carb-x-funds-venatorx-to-support-development-of-new-class-of-oral-antibiotics-to-treat-multi-drug-resistant-gonorrhoea/ 2019-11-26T10:26:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/pill.jpg https://www.pharmaceutical-business-review.com/news/deals/novartis-medicines-company-deal/ 2019-11-26T11:48:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/novartis-tower-with-logo-image-2.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-oxbryta-voxelotor-the-first-medicine-specifically-targeting-the-root-cause-of-sickle-cell-disease/ 2019-11-27T10:06:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/lonza-and-dinaqor-announce-strategic-collaboration-to-advance-gene-therapy-programs-for-patients-with-monogenic-cardiomyopathies/ 2019-11-27T10:10:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/dna-1903318_640.jpg https://www.pharmaceutical-business-review.com/news/evofem-biosciences-resubmits-new-drug-application-to-us-fda-for-amphora-for-the-prevention-of-pregnancy/ 2019-11-28T11:02:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDAdrug-6.jpg https://www.pharmaceutical-business-review.com/news/verrica-pharmaceuticals-announces-fda-filing-acceptance-of-nda-for-vp-102-to-treat-molluscum-contagiosum/ 2019-11-28T13:03:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/celltrion-infliximab-remsima-sc/ 2019-11-28T13:42:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/rheumatoid.jpg https://www.pharmaceutical-business-review.com/news/asahi-kasei-veloxis-pharmaceuticals/ 2019-11-28T13:48:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Asahi_Kasei_Nobeoka_Branch_2010.jpg https://www.pharmaceutical-business-review.com/news/ferring-blackstone-gene-therapy/ 2019-11-28T13:48:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/dna-3539309_640.jpg https://www.pharmaceutical-business-review.com/news/novartis-cell-gene-therapies/ 2019-11-29T07:51:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Novartisfacility.jpg https://www.pharmaceutical-business-review.com/news/wuxi-atu-and-genemedicine-sign-development-and-manufacturing-agreement-for-oncolytic-virus-products/ 2019-11-29T09:19:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Virusparticle.jpg https://www.pharmaceutical-business-review.com/news/medincell-receives-19m-grant-for-mdc-wwm-programme/ 2019-11-29T11:05:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/1280px-Bill_and_Melinda_Gates_Foundation_front.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-imfinzi-extensive-stage-sclc/ 2019-11-29T12:10:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/cq5dam.web_.1200.AZ1572_Equipment.jpg https://www.pharmaceutical-business-review.com/news/fda-incyte-nda-pemigatinib/ 2019-11-29T12:10:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/sensorions-seliforant-primary-endpoint/ 2019-12-02T08:53:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Ear.jpg https://www.pharmaceutical-business-review.com/news/lunac-therapeutics-led-project-awarded-3-14m-under-innovate-uk-biomedical-catalyst-programme-to-develop-next-generation-anticoagulant/ 2019-12-02T10:55:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/test-214185_6403.jpg https://www.pharmaceutical-business-review.com/news/merck-keytruda-high-risk-nmibc/ 2019-12-03T07:59:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/phathom-pharmaceuticals-announces-initiation-of-pivotal-phase-3-clinical-trial-for-vonoprazan-in-erosive-esophagitis/ 2019-12-03T09:05:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/pharma.jpg https://www.pharmaceutical-business-review.com/news/knopp-biosciences-university-of-leicester-release-details-of-phase-2-trial-of-dexpramipexole-in-severe-eosinophilic-asthma/ 2019-12-03T09:47:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/1920px-University_of_Leicester_towers_2010.jpg https://www.pharmaceutical-business-review.com/news/stada-biopharma-ukraine-deal/ 2019-12-03T11:04:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/stada_headquarter_building_bad_vilbel.jpg https://www.pharmaceutical-business-review.com/news/iontas-and-adaptate-biotherapeutics-collaborate-to-identify-optimised-antibodies-for-novel-cancer-targets/ 2019-12-04T09:41:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/bacteria.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-acceleron-announce-fda-advisory-committee-will-review-reblozyl-for-use-in-patients-with-mds/ 2019-12-04T10:21:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/astellas-audentes-therapeutics/ 2019-12-04T10:57:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Audent.jpg https://www.pharmaceutical-business-review.com/news/roche-tecentriq-metastatic-nsclc/ 2019-12-05T07:38:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Rochebuild.jpg https://www.pharmaceutical-business-review.com/news/aws-announces-strategic-collaboration-with-novartis-to-accelerate-digital-transformation-of-its-business-operations/ 2019-12-05T10:06:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/NOvar.jpg https://www.pharmaceutical-business-review.com/news/gatehouse-bio-collaborates-with-astrazeneca-to-accelerate-new-drug-discovery/ 2019-12-05T10:55:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-orencia/ 2019-12-06T08:13:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/BMSfacility.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-seroquel-cheplapharm/ 2019-12-06T08:13:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/meitheal-pharmaceuticals-announces-fda-approval-of-enoxaparin-sodium-injection-usp/ 2019-12-06T08:59:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/fergenes-phase-3-nmibc-study-of-nadofaragene-firadenovec-meets-primary-endpoint/ 2019-12-06T09:39:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/dna-163466_640.jpg https://www.pharmaceutical-business-review.com/news/limelight-bio-emerges-with-75m-to-develop-next-generation-gene-therapies-to-overcome-limitations-of-current-treatments/ 2019-12-06T13:17:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/pill.jpg https://www.pharmaceutical-business-review.com/news/calquence-significantly-prolonged-time-patients-lived-without-disease-progression-or-death-in-previously-untreated-cll/ 2019-12-09T09:17:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/tablet.jpg https://www.pharmaceutical-business-review.com/news/kites-yescarta-yields-positive-results-in-zuma-1-trial-in-refractory-large-b-cell-lymphoma/ 2019-12-09T10:57:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/science-1336663_640.jpg https://www.pharmaceutical-business-review.com/news/xbiotech-bermekimab-janssen/ 2019-12-09T12:42:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/job-4131482_6402.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-fostemsavir-hiv-1/ 2019-12-09T12:42:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/HIVvirus.jpg https://www.pharmaceutical-business-review.com/news/merck-biopharmaceutical-arqule/ 2019-12-10T07:33:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Orcule.jpg https://www.pharmaceutical-business-review.com/news/incheon-city-envisions-biotech-mecca-by-developing-songdo-global-biotech-cluster/ 2019-12-10T09:38:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/IFEZ.jpg https://www.pharmaceutical-business-review.com/news/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-in-us-patients-when-used-in-real-world-setting/ 2019-12-10T10:24:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/novartis-hq-1.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbs-liso-cel/ 2019-12-10T13:05:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/BMSfacility-1.jpg https://www.pharmaceutical-business-review.com/news/amneal-generic-avkar/ 2019-12-11T07:32:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Amneal.jpg https://www.pharmaceutical-business-review.com/news/retrogenix-and-resonant-therapeutics-announce-strategic-alliance-to-identify-targets-of-anti-tumour-antibodies/ 2019-12-11T09:17:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/virusparticle.jpg https://www.pharmaceutical-business-review.com/news/vedanta-biosciences-initiates-first-in-patient-study-of-ve800-in-combination-with-bristol-myers-squibbs-opdivo/ 2019-12-11T10:24:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/cancer-cells-541954_640.jpg https://www.pharmaceutical-business-review.com/news/sanofi-acquire-synthorx-deal/ 2019-12-11T12:06:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/800px-Sanofi_Frankfurt_IPH.jpg https://www.pharmaceutical-business-review.com/news/trastuzumab-deruxtecan-achieves-tumour-response-rate-of-60-9-in-pivotal-phase-ii-her2-positive-metastatic-breast-cancer-trial/ 2019-12-12T11:39:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Astra.jpg https://www.pharmaceutical-business-review.com/news/fully-human-bcma-car-t-clinical-results-to-treat-relapsed-refractory-multiple-myeloma-co-developed-by-iaso-bio-and-innovent-presented-at-the-2019-ash-annual-meeting/ 2019-12-12T11:42:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/ASH.jpg https://www.pharmaceutical-business-review.com/news/leo-pharma-tralokinumab-dermatitis/ 2019-12-13T09:56:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Atopy.jpg https://www.pharmaceutical-business-review.com/news/dermira-lebrikizumab-fda-fast-track/ 2019-12-13T09:56:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-accelerated-approval-to-first-targeted-treatment-for-rare-dmd-mutation/ 2019-12-13T11:35:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/roches-fixed-dose-subcutaneous-combination-of-perjeta-and-herceptin-comparable-to-intravenous-formulations-in-people-with-her2-positive-breast-cancer/ 2019-12-13T11:37:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Rochebuild.jpg https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-votes-unanimously-to-support-use-of-teprotumumab-to-treat-thyroid-eye-disease/ 2019-12-16T10:28:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/genentech-announces-results-of-imspire150-study-in-braf-v600-mutation-positive-advanced-melanoma/ 2019-12-16T11:19:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/genetech-0081967.jpg https://www.pharmaceutical-business-review.com/news/jardiance-phase-3-exercise-ability-studies/ 2019-12-16T12:45:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/1024px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/3m-drug-delivery-altaris-capital/ 2019-12-16T12:45:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/thermometer-1539191_640.jpg https://www.pharmaceutical-business-review.com/news/organovo-and-tarveda-therapeutics-announce-definitive-merger-agreement/ 2019-12-17T09:36:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Organo.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-closes-deal-with-cheplapharm-for-rights-to-seroquel-and-seroquel-xr-in-europe-and-russia/ 2019-12-17T10:52:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/xtandi-prostate-cancer-fda/ 2019-12-17T13:05:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/novartis-fevipiprant-asthma-studies/ 2019-12-17T13:05:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/novartis-tower.jpg https://www.pharmaceutical-business-review.com/news/ec-grants-dicerna-deficiency/ 2019-12-18T07:50:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Liverorgan.png https://www.pharmaceutical-business-review.com/uncategorized/pear-therapeutics-announces-first-patient-dosed-in-part-ii-of-pear-006-feasibility-study/ 2019-12-18T09:36:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Kidney.jpg https://www.pharmaceutical-business-review.com/news/amylyx-pharmaceuticals-announces-amx0035-demonstrated-statistically-significant-treatment-benefit-in-als-in-centaur-trial/ 2019-12-18T10:50:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/lab-3498584_640.jpg https://www.pharmaceutical-business-review.com/news/charles-river-laboratories-hemacare/ 2019-12-18T12:42:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Hemacare.jpg https://www.pharmaceutical-business-review.com/news/us-fda-accepts-and-grants-priority-review-to-snda-for-braftovi-in-combination-with-erbitux-to-treat-brafv600e-mutant-metastatic-colorectal-cancer-after-prior-therapy/ 2019-12-19T10:17:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/arcus-collaborates-with-genentech-for-two-randomised-clinical-studies-of-ab928/ 2019-12-19T10:46:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/cancer-cells-541954_6401.jpg https://www.pharmaceutical-business-review.com/news/astellas-seattle-genetics-get-fdas-accelerated-approval-for-bladder-cancer-drug-padcev/ 2019-12-20T07:56:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Padcev.jpg https://www.pharmaceutical-business-review.com/news/keytruda-high-risk-nmibc-odac/ 2019-12-20T07:56:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/roche-kadcyla-breast-cancer/ 2019-12-20T08:01:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Basel-1.jpg https://www.pharmaceutical-business-review.com/news/achillion-shareholders-approve-agreement-to-be-acquired-by-alexion/ 2019-12-20T09:28:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Achillion.jpg https://www.pharmaceutical-business-review.com/news/exelixis-enters-into-a-clinical-collaboration-for-three-phase-3-combination-trials-in-advanced-solid-tumours/ 2019-12-20T11:14:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/test-214185_6404.jpg https://www.pharmaceutical-business-review.com/news/acceleron-fulcrum-pulmonary-research/ 2020-01-02T07:53:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Acceleron.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-pancreatic-lynparza/ 2020-01-02T07:53:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/Astratablet.jpg https://www.pharmaceutical-business-review.com/news/ipsen-dysport-cerebral-palsy/ 2020-01-06T08:24:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Ipsen.jpg https://www.pharmaceutical-business-review.com/news/amgen-beigene-oncology-china/ 2020-01-06T08:25:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/hires-illumina-building-entrance.jpg https://www.pharmaceutical-business-review.com/news/gsk-vaccine-brands-bavarian-nordic/ 2020-01-06T08:25:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/gsk-house-location-building.jpg https://www.pharmaceutical-business-review.com/news/leap-therapeutics-and-beigene-announce-exclusive-option-and-license-agreement-for-dkn-01/ 2020-01-06T12:06:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/job-4131482_6404.jpg https://www.pharmaceutical-business-review.com/news/merck-enters-into-2-5bn-oncology-deal-with-taiho-and-astex/ 2020-01-07T09:27:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/drug-target-1.jpg https://www.pharmaceutical-business-review.com/news/veristat-strengthens-its-european-presence-with-acquisition-of-the-clinical-trial-company/ 2020-01-07T10:00:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Trial.jpg https://www.pharmaceutical-business-review.com/news/glycomimetics-apollomics-announce-collaboration-and-license-agreement-for-gmi-1687/ 2020-01-07T11:25:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/deal-4131445_6401.jpg https://www.pharmaceutical-business-review.com/news/farxiga-fda-priority-review-heart-failure/ 2020-01-07T12:52:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/deals/charles-river-laboratories-hemacare-2/ 2020-01-07T12:54:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/handshake-3655926_6403.jpg https://www.pharmaceutical-business-review.com/news/incyte-announces-validation-by-ema-of-its-maa-for-pemigatinib-in-patients-with-cholangiocarcinoma/ 2020-01-08T10:44:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Carcinoma.jpg https://www.pharmaceutical-business-review.com/news/sab-biotherapeutics-announces-research-collaboration-with-csl-behring/ 2020-01-08T10:58:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/business-4107640_640.jpg https://www.pharmaceutical-business-review.com/news/schrodinger-bayer-collaborate-to-co-develop-de-novo-design-technology-to-accelerate-drug-discovery/ 2020-01-09T08:44:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/tablet.jpg https://www.pharmaceutical-business-review.com/news/catabasis-duchenne-uk-announce-partnership-to-evaluate-edasalonexent-in-phase-2-non-ambulatory-dmd-trial/ 2020-01-09T11:14:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/laboratory-3827745_6402.jpg https://www.pharmaceutical-business-review.com/news/bicycle-therapeutics-cancer-research/ 2020-01-09T11:16:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Bicycle.jpg https://www.pharmaceutical-business-review.com/news/merck-keytruda-nmibc/ 2020-01-10T08:11:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/tyme-eagle-sm-88-advanced-cancers/ 2020-01-10T08:11:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/cancer-cells-541954_6402.jpg https://www.pharmaceutical-business-review.com/uncategorized/gho-capital-acquires-cdmo-ardena/ 2020-01-10T10:01:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/CDMO.jpg https://www.pharmaceutical-business-review.com/news/vbi-vaccines-announces-second-pivotal-phase-3-study-of-sci-b-vac-meets-primary-and-secondary-endpoints/ 2020-01-10T11:29:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/syringe-1884758_640.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-licences-portfolio-of-hiv-antibodies-from-the-rockefeller-university/ 2020-01-10T14:26:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/HIV.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-dermira/ 2020-01-13T08:15:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Eli-Lilly.jpg https://www.pharmaceutical-business-review.com/news/neurobo-pharmaceuticals-and-gemphire-therapeutics-complete-merger/ 2020-01-13T09:45:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Merger.jpg https://www.pharmaceutical-business-review.com/news/alnylam-initiates-rolling-submission-of-nda-for-lumasiran-in-primary-hyperoxaluria-type-1/ 2020-01-13T11:07:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-fostemsavir-ema/ 2020-01-13T12:40:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/hiv-1903373_640.jpg https://www.pharmaceutical-business-review.com/news/empirico-ionis-antisense-therapeutics/ 2020-01-13T12:41:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Drug-pill.jpg https://www.pharmaceutical-business-review.com/news/charles-river-takeda-announce-scientific-collaboration-to-identify-and-develop-preclinical-candidates/ 2020-01-14T09:48:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Takedbuild.jpg https://www.pharmaceutical-business-review.com/news/biomotiv-and-atomwise-sign-ai-partnership-to-transform-therapeutic-development/ 2020-01-14T11:21:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/artificial-intelligence-3382507_6403.jpg https://www.pharmaceutical-business-review.com/news/bayer-contraceptive-ovaprene/ 2020-01-16T07:27:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Bayer.jpg https://www.pharmaceutical-business-review.com/news/twist-bioscience-announces-strategic-collaboration-with-schrodinger-for-drug-discovery/ 2020-01-16T10:03:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Scrodinger.jpg https://www.pharmaceutical-business-review.com/news/fda-accepts-for-priority-review-bristol-myers-squibbs-application-for-opdivo-plus-yervoy-in-first-line-nsclc/ 2020-01-16T11:14:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-dovato/ 2020-01-17T07:43:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/HIVinfection.jpg https://www.pharmaceutical-business-review.com/news/deals/astellas-adaptimmune-t-cell-therapy/ 2020-01-17T07:44:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/dna-1903318_6401.jpg https://www.pharmaceutical-business-review.com/news/neuroptika-announces-enrolment-of-first-patient-in-phase-2-clinical-trial-for-dry-eye-disease/ 2020-01-17T09:47:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Dry-eye.jpg https://www.pharmaceutical-business-review.com/news/civica-rx-partners-with-thermo-fisher-scientific-to-develop-and-manufacture-drugs-with-a-history-of-drug-shortages/ 2020-01-17T11:12:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/800px-ThermoFisherScientific2.jpg https://www.pharmaceutical-business-review.com/news/clarivate-analytics-decision-resources/ 2020-01-20T08:07:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Piramal.jpg https://www.pharmaceutical-business-review.com/news/innovation-pharmaceuticals-announces-dose-escalation/ 2020-01-20T09:38:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/tablet-1.jpg https://www.pharmaceutical-business-review.com/news/verrica-pharmaceuticals-announces-presentation-of-positive-data-from-new-pooled-analysis-of-phase-3-camp-trials-of-vp-102/ 2020-01-20T11:16:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/test-214185_6405.jpg https://www.pharmaceutical-business-review.com/news/merck-biopharmaceutical-firm-arqule/ 2020-01-20T13:02:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Arcule.jpg https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-receives-eu-marketing-authorisation-for-sunosi-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-osa/ 2020-01-21T09:08:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Jazztablet.jpg https://www.pharmaceutical-business-review.com/news/armas-pharmaceuticals-adds-four-generic-injectables-as-first-launches-of-2020/ 2020-01-21T09:48:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/syringe-1884758_6401.jpg https://www.pharmaceutical-business-review.com/news/novartis-mayzent-smps-eu/ 2020-01-21T13:04:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/novartis-hq-1.jpg https://www.pharmaceutical-business-review.com/news/janssen-imbruvica-rituximab-ema/ 2020-01-21T13:04:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/IMBRUVICAProductSh_1540765104569-HR.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-pharmaceutical-north-carolina/ 2020-01-22T08:27:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Eli-Lilly-1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-tremelimumab-carcinoma/ 2020-01-22T08:28:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Astra.jpg https://www.pharmaceutical-business-review.com/news/calidi-biotherapeutics-secures-series-a-investments-to-advance-manufacturing/ 2020-01-22T10:40:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Calidi_Biotherapeutics.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-tepezza-for-the-treatment-of-thyroid-eye-disease/ 2020-01-22T10:59:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/12/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/roches-risdiplam-spinal-muscular/ 2020-01-23T08:00:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Basel-1.jpg https://www.pharmaceutical-business-review.com/news/novel-coronavirus-us-patient/ 2020-01-23T08:01:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/lossy-page1-800px-CDC_Headquarters_PHIL_10693.tif.jpg https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-submits-nda-for-jzp-258-for-cataplexy-and-excessive-daytime-sleepiness-associated-with-narcolepsy/ 2020-01-23T10:15:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/lb-pharmaceuticals-initiates-patient-dosing-in-phase-1-study-of-lb-102-for-treatment-of-schizophrenia/ 2020-01-23T11:12:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/test-214185_6406.jpg https://www.pharmaceutical-business-review.com/news/highres-biosolutions-and-novo-nordisk-partner-to-transform-drug-discovery-in-automated-lab-of-future/ 2020-01-27T10:10:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/drug.jpg https://www.pharmaceutical-business-review.com/news/lexicon-pharmaceuticals-announces-real-world-data-on-telotristat-ethyls-antiproliferative-effects-in-patients-with-carcinoid-syndrome/ 2020-01-27T10:15:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/test-214185_6407.jpg https://www.pharmaceutical-business-review.com/news/ds-8201-destiny-gastric01-trial/ 2020-01-27T12:22:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/mitosis-3876669_640.jpg https://www.pharmaceutical-business-review.com/news/epizyme-tazverik-tepithelioid-sarcoma/ 2020-01-27T12:22:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-mercks-dificid-to-treat-clostridioides-difficile-in-children-aged-six-months-and-older/ 2020-01-28T09:48:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/accelerons-sotatercept-achieved-primary-and-secondary-endpoints-in-pulsar-trial-in-pulmonary-arterial-hypertension/ 2020-01-28T10:50:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/laboratory-3827736_640.jpg https://www.pharmaceutical-business-review.com/news/deals/allergan-brazikumab-zenpep-sale/ 2020-01-28T12:02:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Allergan.jpg https://www.pharmaceutical-business-review.com/news/roches-tecentriq-miuc/ 2020-01-28T12:07:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Basel.jpg https://www.pharmaceutical-business-review.com/news/incyte-announces-that-true-ad2-trial-of-ruxolitinib-cream-met-its-primary-endpoint-in-patients-with-atopic-dermatitis/ 2020-01-29T09:46:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/sunburn.jpg https://www.pharmaceutical-business-review.com/news/european-medicines-agency-validates-kites-marketing-application-for-second-car-t-cell-therapy/ 2020-01-29T10:58:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/dna-163466_6401.jpg https://www.pharmaceutical-business-review.com/news/accenture-google-cloud-intient/ 2020-01-29T12:19:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/800px-Googleplex_HQ_cropped.jpg https://www.pharmaceutical-business-review.com/news/atnahs-pharma-astrazeneca-hypertension/ 2020-01-29T12:19:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Astratablet.jpg https://www.pharmaceutical-business-review.com/news/alexion-achillion/ 2020-01-30T07:25:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Achillion.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-launches-multi-pronged-response-to-coronavirus-global-public-health-threat/ 2020-01-30T11:09:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Johnson.jpg https://www.pharmaceutical-business-review.com/news/vasopharm-completes-patient-enrollment-for-phase-3-traumatic-brain-injury-trial-nostra/ 2020-01-30T11:12:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/science-1336663_6401.jpg https://www.pharmaceutical-business-review.com/news/lilly-selpercatinib-fda-priority-review/ 2020-01-31T07:14:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/800px-2006_0219FirstFUJIFOLDER0012.jpg https://www.pharmaceutical-business-review.com/news/pulmatrix-receives-fast-track-designation-for-pulmazole-for-the-treatment-of-asthma-abpa/ 2020-01-31T10:35:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/first-patient-with-advanced-breast-cancer-receives-first-dose-in-clinical-trial-of-glycomimetics-gmi-1359/ 2020-01-31T10:38:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/test-214185_6408.jpg https://www.pharmaceutical-business-review.com/news/pfizer-receives-positive-chmp-opinion-for-oncology-biosimilar-ruxience/ 2020-02-03T09:42:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-withdraws-european-application-of-opdivo-plus-yervoy-for-first-line-treatment-of-advanced-nsclc/ 2020-02-03T11:22:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/aimmune-palforzia-peanut-allergy-fda/ 2020-02-03T12:21:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Aimmune_PALFORZIA_Capsule_Image_FDA_Approval-scaled-e1580730690469.jpg https://www.pharmaceutical-business-review.com/news/aprea-therapeutics-apr-246-fda/ 2020-02-03T12:21:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/800px-FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/teva-announces-positive-top-line-results-from-ajovy-clinical-trials-in-japan/ 2020-02-04T09:16:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Teva.jpg https://www.pharmaceutical-business-review.com/news/bio-thera-solutions-announces-positive-top-line-results-for-bat1706-a-proposed-biosimilar-to-avastin/ 2020-02-04T10:00:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/test-214185_6409.jpg https://www.pharmaceutical-business-review.com/news/gsk-cepi-coronavirus/ 2020-02-04T12:58:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Corona.png https://www.pharmaceutical-business-review.com/news/immix-doses-first-patient-in-us-in-its-phase-1b-2a-trial-in-patients-with-advanced-solid-tumours/ 2020-02-05T09:26:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Cancer.jpg https://www.pharmaceutical-business-review.com/news/rebiotix-a-ferring-company-completes-enrollment-for-phase-3-clinical-trial-of-microbiota-based-rbx2660/ 2020-02-05T09:33:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/test-214185_64010.jpg https://www.pharmaceutical-business-review.com/news/recarbrio-habp-vabp-priority-review/ 2020-02-05T11:23:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/catalent-cdmo-masthercell/ 2020-02-05T12:20:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Catalent.jpg https://www.pharmaceutical-business-review.com/news/biomotiv-anteros-pharmaceuticals/ 2020-02-06T07:58:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Anteros.jpg https://www.pharmaceutical-business-review.com/news/genprex-to-focus-its-clinical-efforts-on-oncoprex-in-combination-therapy-with-osimertinib-for-nsclc/ 2020-02-06T09:40:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Cancer-1.jpg https://www.pharmaceutical-business-review.com/news/alk-abello-and-x-chem-announce-drug-discovery-collaboration/ 2020-02-06T10:35:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/science-1336663_6402.jpg https://www.pharmaceutical-business-review.com/news/aimmune-xencor-food-allergy/ 2020-02-07T07:59:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Vegetable.jpg https://www.pharmaceutical-business-review.com/news/regeneron-novel-coronavirus-antibodies/ 2020-02-07T07:59:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-New_Eastview_office_bldg_jeh.jpg https://www.pharmaceutical-business-review.com/news/realta-life-sciences-announces-fda-orphan-drug-designation-for-pic1-to-treat-hypoxic-ischemic-encephalopathy/ 2020-02-07T09:34:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/azafaros-completes-eur25m-series-a-financing-to-advance-rare-metabolic-disorders-pipeline/ 2020-02-07T11:03:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/handshake-3298455_64028.jpg https://www.pharmaceutical-business-review.com/news/roche-gantenerumab-alzheimers-disease/ 2020-02-10T07:59:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Basel.jpg https://www.pharmaceutical-business-review.com/news/valeritas-announces-agreement-for-zealand-pharma-to-acquire-business-and-retain-employees/ 2020-02-10T10:05:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Zealand.jpg https://www.pharmaceutical-business-review.com/news/elios-therapeutics-presents-new-phase-iib-data-for-personalized-cancer-vaccine-in-high-risk-melanoma-patients/ 2020-02-10T10:49:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/syringe-4544448_6401.jpg https://www.pharmaceutical-business-review.com/news/apollo-covis-pharma/ 2020-02-10T13:18:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Clovis.jpg https://www.pharmaceutical-business-review.com/news/biohavens-troriluzole-study-for-generalised-anxiety-disorder-misses-primary-endpoint/ 2020-02-11T10:09:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Pharmatab.jpg https://www.pharmaceutical-business-review.com/news/moderna-announces-progress-in-prophylactic-vaccines-modality-with-cmv-vaccine-phase-2-study-data-now-expected-in-third-quarter-2020/ 2020-02-11T10:13:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/syringe-4544448_6402.jpg https://www.pharmaceutical-business-review.com/news/lilly-solanezumab-dian-tu-study/ 2020-02-11T12:04:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/eylea-panorama-trial-results/ 2020-02-11T12:05:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/EYLEAProductShot_1555343687374-HR.png https://www.pharmaceutical-business-review.com/news/ligand-agrees-to-acquire-core-assets-partnered-programmes-and-ion-channel-technologies-from-icagen/ 2020-02-12T09:57:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Ligand.jpg https://www.pharmaceutical-business-review.com/news/deals/dr-reddys-laboratories-to-acquire-select-business-divisions-of-wockhardt-in-india/ 2020-02-12T10:37:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Dr._Reddys_Finished_Dosage_Facility_III.jpg https://www.pharmaceutical-business-review.com/news/capmatinib-fda-priority-review/ 2020-02-12T12:10:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/novartis-tower-with-logo-image-scaled-e1581507207268.jpg https://www.pharmaceutical-business-review.com/news/nanobiotix-nbtxr3-head-neck/ 2020-02-12T12:11:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/pfizer-astellas-xtandi/ 2020-02-13T08:39:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/deciphera-pharmaceuticals-announces-us-fda-acceptance-of-nda-and-priority-review-for-ripretinib-in-patients-with-advanced-gastrointestinal-stromal-tumours/ 2020-02-13T10:06:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/alx-oncology-announces-closing-of-105m-series-c-financing/ 2020-02-13T10:58:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/business-4107640_64010.jpg https://www.pharmaceutical-business-review.com/news/merck-keytruda-mtnbc-trial/ 2020-02-14T08:05:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/the-us-fda-accepts-for-priority-review-bristol-myers-squibbs-bla-for-liso-cel-for-adult-patients-with-relapsed-or-refractory-large-b-cell-lymphoma/ 2020-02-14T09:48:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/BMS.jpg https://www.pharmaceutical-business-review.com/news/seattle-genetics-gets-fda-priority-review-for-tucatinib-in-locally-advanced-or-metastatic-her2-positive-breast-cancer/ 2020-02-14T10:56:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/epizyme-seeks-fda-accelerated-approval-for-tazverik-to-treat-follicular-lymphoma/ 2020-02-17T08:01:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/new-phase-3b-interim-data-from-stardust-study-show-majority-patients-with-moderately-to-severely-active-crohns-disease-achieved-clinical-remission-after-two-doses-of-stelara/ 2020-02-17T10:24:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/JandJ.jpg https://www.pharmaceutical-business-review.com/news/celltrion-showcases-positive-one-year-results-for-subcutaneous-formulation-of-infliximab-in-patients-with-active-crohns-disease-and-ulcerative-colitis/ 2020-02-17T11:31:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/laboratory-3827745_6403.jpg https://www.pharmaceutical-business-review.com/news/roche-chinese-tecentriq-chemotherapy/ 2020-02-17T12:27:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Basel-1.jpg https://www.pharmaceutical-business-review.com/news/ascletis-ind-filing-for-its-nash-drug-accepted-by-nmpa/ 2020-02-18T10:00:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Liver.png https://www.pharmaceutical-business-review.com/news/fda-approves-gsks-voltaren-arthritis-pain-for-over-the-counter-use-in-the-us/ 2020-02-18T10:44:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/lurbinectedin-fda-priority-review/ 2020-02-18T12:11:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/cancer-cells-541954_6403.jpg https://www.pharmaceutical-business-review.com/news/opdivo-checkmate-025-study/ 2020-02-18T12:12:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Bristol-Myers-Squibb_Pharmaceutical_Research_Institute-by-Sue-Adair.jpg https://www.pharmaceutical-business-review.com/news/alx-oncologys-alx148-receives-two-fast-track-designations-from-fda/ 2020-02-19T08:31:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-4.jpg https://www.pharmaceutical-business-review.com/news/merck-receives-complete-response-letter-from-fda-for-sblas-for-keytruda-six-week-dosing-schedule/ 2020-02-19T09:30:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/novartis-beovu-wet-amd/ 2020-02-19T12:47:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Novar.jpg https://www.pharmaceutical-business-review.com/news/audentes-therapeutics-gene/ 2020-02-20T08:02:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Audentus.jpg https://www.pharmaceutical-business-review.com/news/humanetics-acquires-manufacturing-assets-for-radioprotectant-drug/ 2020-02-20T09:46:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/drug.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-genentechs-tecentriq-as-first-line-treatment-of-certain-people-with-advanced-nsclc/ 2020-02-20T10:53:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/genetech-0081967.jpg https://www.pharmaceutical-business-review.com/news/seattle-genetics-astellas/ 2020-02-21T06:51:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-5.jpg https://www.pharmaceutical-business-review.com/news/pfizer-vyndaqel-ec-approval/ 2020-02-21T06:51:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/forma-therapeutics-announces-ft-4202-granted-fast-track-designation-and-rare-paediatric-disease-designation-to-treat-sickle-cell-disease/ 2020-02-21T08:38:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-6.jpg https://www.pharmaceutical-business-review.com/news/first-patient-dosed-with-transgenes-tg6002-in-colorectal-cancer-with-liver-metastases/ 2020-02-21T10:11:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/science-1336663_6403.jpg https://www.pharmaceutical-business-review.com/news/genetron-health-innocare-collaborate-to-accelerate-development-and-commercialisation-of-novel-drugs-for-cancer-treatment/ 2020-02-24T09:41:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Tablet.jpg https://www.pharmaceutical-business-review.com/news/harbour-biomed-announces-completion-of-phase-1-study-in-china-of-hbm9161-an-anti-fcrn-antibody/ 2020-02-24T10:46:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/test-214185_64011.jpg https://www.pharmaceutical-business-review.com/news/lilly-trulicity-approval-fda/ 2020-02-24T12:27:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA-1.jpg https://www.pharmaceutical-business-review.com/news/gsk-immatics-cancer-therapies/ 2020-02-24T12:30:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/GSK-building.jpg https://www.pharmaceutical-business-review.com/news/shionogis-fetroja-now-available-for-treatment-of-complicated-urinary-tract-infections-in-us/ 2020-02-25T09:36:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Fetroja.jpg https://www.pharmaceutical-business-review.com/news/pandion-announces-first-subject-dosed-in-phase-1-trial-of-pt101-an-il-2-mutein-fc-fusion-therapy-for-autoimmune-disease/ 2020-02-25T11:01:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/laboratory-3827745_6404.jpg https://www.pharmaceutical-business-review.com/news/alunbrig-fda-priority-review-nsclc/ 2020-02-25T13:01:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Takeda-Midosuji-Bldg-01.jpg https://www.pharmaceutical-business-review.com/news/lundbeck-migraine-vyepti/ 2020-02-25T13:02:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Lundbeck.jpg https://www.pharmaceutical-business-review.com/news/lysogene-receives-fda-fast-track-designation-for-lys-saf302-gene-therapy-in-mps-iiia/ 2020-02-26T08:34:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-7.jpg https://www.pharmaceutical-business-review.com/news/deals/astrazeneca-divests-global-rights-to-movantik/ 2020-02-26T09:29:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/gsk-clover-coronavirus-vaccine/ 2020-02-26T12:26:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Corona-1.png https://www.pharmaceutical-business-review.com/news/genentech-bicycle-therapeutics/ 2020-02-27T10:34:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Genetech.jpg https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-votes-in-favour-of-lillys-cyramza-as-first-line-treatment-for-metastatic-egfr-mutated-nsclc/ 2020-02-27T10:54:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Eli-Lilly-1.jpg https://www.pharmaceutical-business-review.com/news/jtakeda-pvp-biologics/ 2020-02-28T08:12:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Takedabuild.jpg https://www.pharmaceutical-business-review.com/news/novartis-dndi-lxe408-visceral-leishmaniasis/ 2020-02-28T08:12:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/novartis-tower-with-logo-image-1-scaled.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-enters-discovery-stage-collaboration-with-trutino-biosciences/ 2020-02-28T09:14:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Medicine-tablet.jpg https://www.pharmaceutical-business-review.com/news/harbour-biomed-receives-fda-ind-approval-for-phase-2-trial-and-orphan-drug-designation-for-hbm9167/ 2020-02-28T10:14:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/medexus-expands-its-us-product-portfolio-by-acquiring-hematology-asset-ixinity/ 2020-03-02T10:40:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Hema.jpg https://www.pharmaceutical-business-review.com/news/verastem-oncology-announces-new-strategic-direction-to-advance-its-clinical-development-programmes/ 2020-03-02T11:28:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/laptop-3196481_64017.jpg https://www.pharmaceutical-business-review.com/news/harbour-biomed-hbm4003-fda/ 2020-03-02T12:57:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/cancer-cells-541954_6404.jpg https://www.pharmaceutical-business-review.com/news/gsk-innoviva-trelegy-ellipta-2/ 2020-03-02T12:58:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/GSK-building-1.jpg https://www.pharmaceutical-business-review.com/news/takeda-completes-sale-of-select-otc-and-non-core-assets-to-acino/ 2020-03-03T09:24:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Takeda.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-completes-divestment-agreement-with-atnahs-pharma-for-established-hypertension-medicines/ 2020-03-03T10:46:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/advil-dual-action-with-acetaminophen-fda/ 2020-03-03T12:36:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Glaxo_Smith_Kline_Offices_on_the_Great_West_Road_at_Brentford_-_panoramio.jpg https://www.pharmaceutical-business-review.com/news/emas-chmp-boehringers-nintedanib-to-treat-ssc-ild/ 2020-03-03T12:36:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Boehringer.jpg https://www.pharmaceutical-business-review.com/news/ayala-pharmaceuticals-granted-us-fda-fast-track-designation-for-al101-to-treat-recurrent-or-metastatic-adenoid-cystic-carcinoma/ 2020-03-04T08:54:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/akouos-closes-105m-series-b-financing/ 2020-03-04T10:29:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/shaking-hands-3091906_6407.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-forty-seven/ 2020-03-04T12:27:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Gilead.jpg https://www.pharmaceutical-business-review.com/news/alnylam-givlaari-hepatic-porphyria/ 2020-03-05T08:32:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Eurobuilding.jpg https://www.pharmaceutical-business-review.com/news/scientists-from-merck-and-the-walter-and-eliza-hall-institute-of-medical-research-discover-novel-class-of-candidate-anti-malaria-agents/ 2020-03-05T10:28:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Mosquito.jpg https://www.pharmaceutical-business-review.com/news/amunix-raises-73m-in-series-a-financing-led-by-omega-funds/ 2020-03-05T11:25:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/handshake-3298455_640.jpg https://www.pharmaceutical-business-review.com/news/takeda-plasma-covid-19/ 2020-03-06T07:49:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Corona.png https://www.pharmaceutical-business-review.com/news/iktos-sri-covid-19-drug-discovery/ 2020-03-06T07:49:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/artificial-intelligence-3382507_6406.jpg https://www.pharmaceutical-business-review.com/news/urovant-sciences-announces-us-fda-acceptance-of-nda-for-vibegron-to-treat-overactive-bladder/ 2020-03-06T09:24:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Dental.jpg https://www.pharmaceutical-business-review.com/news/biocryst-begins-proof-of-concept-trial-in-pnh-patients-with-oral-factor-d-inhibitor-bcx9930/ 2020-03-06T09:31:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/test-214185_640.jpg https://www.pharmaceutical-business-review.com/news/mount-sinai-and-harbour-biomed-collaborate-to-advance-novel-biotherapies-to-treat-cancer-and-coronavirus-covid-19/ 2020-03-09T09:49:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/coronavirus.jpg https://www.pharmaceutical-business-review.com/news/deals/abbvie-receives-marketing-authorisation-from-ec-to-shorten-maviret-duration-for-treatment-naive-genotype-3-hcv-patients-with-compensated-cirrhosis/ 2020-03-09T09:51:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/AbbVieUS.jpg https://www.pharmaceutical-business-review.com/news/novartis-isturisa-cushings-disease/ 2020-03-10T05:54:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/novartis-tower.jpg https://www.pharmaceutical-business-review.com/news/zydus-cirrhotic-nash-india/ 2020-03-10T05:54:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/zydus-cadila-plant.jpg https://www.pharmaceutical-business-review.com/news/kuur-therapeutics-launches-to-develop-and-commercialise-off-the-shelf-car-nkt-cell-therapies/ 2020-03-11T09:45:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Virus.jpg https://www.pharmaceutical-business-review.com/news/inmed-pharmaceuticals-announces-completed-enrollment-in-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2020-03-11T11:40:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/test-214185_640-1.jpg https://www.pharmaceutical-business-review.com/news/tourmaline-mm2-study-results/ 2020-03-11T12:56:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/692px-Takeda-Midosuji-Bldg-01.jpg https://www.pharmaceutical-business-review.com/news/kalas-kpi-121-stride-3-trial/ 2020-03-11T12:56:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/lab-3498584_640.jpg https://www.pharmaceutical-business-review.com/news/brii-biosciences-provides-funding-to-columbia-university-for-research-on-covid-19-and-other-coronaviruses/ 2020-03-12T10:02:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/covid.png https://www.pharmaceutical-business-review.com/news/silverback-therapeutics-raises-78-5m-in-oversubscribed-series-b-financing/ 2020-03-12T10:42:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/office-1209640_6401.jpg https://www.pharmaceutical-business-review.com/news/janssen-jnj-6372-nsclc/ 2020-03-12T12:26:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Johnson.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-opdivo/ 2020-03-13T07:42:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/BMSfacility.jpg https://www.pharmaceutical-business-review.com/news/artugen-therapeutics-announces-first-patient-dosed-with-art24/ 2020-03-13T09:31:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/clostridium.jpg https://www.pharmaceutical-business-review.com/news/fda-clears-first-clinical-study-for-a-polymicrobial-phage-library-based-treatment-for-antibiotic-resistant-infections/ 2020-03-13T10:13:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-jardiance-kidney/ 2020-03-16T07:29:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Lilli.jpg https://www.pharmaceutical-business-review.com/news/forty-seven-rocket-fanconi-anemia/ 2020-03-16T07:30:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/business-4107640_640.jpg https://www.pharmaceutical-business-review.com/news/can-fite-to-explore-the-anti-coronavirus-effects-of-piclidenoson-in-collaboration-with-lewis-katz-school-of-medicine-at-temple-university/ 2020-03-16T11:10:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/epidemic-4888794_640.jpg https://www.pharmaceutical-business-review.com/news/biostem-life-sciences-announces-expansion-contract-manufacturing-capabilities-and-research-and-development-laboratory/ 2020-03-16T11:13:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/lab-3498584_6401.jpg https://www.pharmaceutical-business-review.com/news/acelrx-pharmaceuticals-to-acquire-tetraphase-pharmaceuticals/ 2020-03-17T09:42:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/acquire.jpg https://www.pharmaceutical-business-review.com/news/aurinia-initiates-rolling-submission-of-a-new-drug-application-to-the-fda-for-voclosporin-in-the-treatment-of-lupus-nephritis/ 2020-03-17T09:44:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/moderna-mrna-1273-coronavirus-trial/ 2020-03-17T12:49:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/covid-19-4907621_640.jpg https://www.pharmaceutical-business-review.com/news/pfizer-emd-serono-avelumab-la-scchn/ 2020-03-17T12:49:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-vaccine-covid-19/ 2020-03-18T07:35:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/lilly-incyte-baricitinib/ 2020-03-18T07:36:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Lilli-1.jpg https://www.pharmaceutical-business-review.com/news/merck-announces-top-line-results-from-phase-3-trials-evaluating-gefapixant/ 2020-03-18T09:41:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/tablet.jpg https://www.pharmaceutical-business-review.com/news/ribomic-enters-license-agreement-with-aju-pharma-for-rbm-007-in-age-related-macular-degeneration/ 2020-03-18T11:25:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/handshake-3298455_640-1.jpg https://www.pharmaceutical-business-review.com/news/dicerna-receives-orphan-drug-designation-from-fda-for-dcr-a1at-to-treat-alpha-1-antitrypsin-deficiency/ 2020-03-19T10:16:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/novartis-announces-nejm-publication-of-three-pivotal-trials-showing-durable-and-potent-efficacy-of-inclisiran/ 2020-03-19T11:16:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/novartis-hq-1.jpg https://www.pharmaceutical-business-review.com/news/pfizer-abrocitinib-jade-compare/ 2020-03-19T14:14:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Pfizerworldheadquartersentrance-1.jpg https://www.pharmaceutical-business-review.com/news/imfinzi-os-benefit-caspian-trial/ 2020-03-19T14:15:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/cq5dam.web_.1200.AZ1572_Equipment.jpg https://www.pharmaceutical-business-review.com/news/roche-actemra-roactemra-pneumonia/ 2020-03-20T07:53:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Basel-1.jpg https://www.pharmaceutical-business-review.com/news/entos-pharmaceuticals-fusogenix-covid-19/ 2020-03-20T07:54:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/coronavirus-4914026_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-new-treatment-for-paediatric-patients-with-any-strain-of-hepatitis-c/ 2020-03-20T09:18:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/novartis-receives-japanese-approval-for-zolgensma-in-spinal-muscular-atrophy/ 2020-03-20T11:25:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/novartis-hq-1.jpg https://www.pharmaceutical-business-review.com/news/amneal-accelerates-distribution-and-production-of-hydroxychloroquine-sulfate-to-meet-potential-needs-of-covid-19-patients-nationwide/ 2020-03-23T11:18:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Corona-1.png https://www.pharmaceutical-business-review.com/news/design-therapeutics-launches-with-45m-to-develop-a-new-class-of-disease-modifying-therapies-for-serious-degenerative-disorders/ 2020-03-23T11:27:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/test-214185_640-1-1.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-cabenuva-approval/ 2020-03-23T12:22:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/hiv-1903372_640.jpg https://www.pharmaceutical-business-review.com/news/feinstein-institutes-covid-19/ 2020-03-24T07:05:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Northwell.jpg https://www.pharmaceutical-business-review.com/news/abbvie-announces-positive-topline-results-from-phase-3-trial-of-venclexta-azacitidine-combo-in-aml/ 2020-03-24T11:25:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Abbvie.jpg https://www.pharmaceutical-business-review.com/news/hoth-therapeutics-announces-agreement-to-joint-development-for-a-self-assembling-vaccine-sav-for-the-potential-prevention-of-coronavirus/ 2020-03-24T11:31:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/epidemic-4952933_640.jpg https://www.pharmaceutical-business-review.com/news/covacta-trial-actemra-covid-19/ 2020-03-25T06:27:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/genetech-0081967.jpg https://www.pharmaceutical-business-review.com/news/xencor-vir-biotechnology-covid/ 2020-03-26T08:12:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Corona-2.png https://www.pharmaceutical-business-review.com/news/alnylam-pharmaceuticals-and-gen-sign-distribution-agreement-in-turkey-for-onpattro-patisiran/ 2020-03-26T11:40:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/handshake-3298455_640-7.jpg https://www.pharmaceutical-business-review.com/news/avexis-zolgensma-sma-trials/ 2020-03-26T14:25:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/dna-1903318_640.jpg https://www.pharmaceutical-business-review.com/news/infinity-ipi-549-urothelial-cancer/ 2020-03-26T14:38:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/FDA-drug-evaluation-research-center.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-squibbs-zeposia-oral-treatment-for-relapsing-forms-of-multiple-sclerosis/ 2020-03-27T09:19:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-designation-to-allovirs-viralym-m/ 2020-03-27T11:37:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/laboratory-3827745_640.jpg https://www.pharmaceutical-business-review.com/news/clinones-remote-clinical-trial-patient-management-technology-allows-pharmaceutical-companies-to-continue-clinical-research-efforts-amidst-covid-19-pandemic-in-accordance-with-fda-guidelines/ 2020-03-28T14:38:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Corona-3.png https://www.pharmaceutical-business-review.com/news/sanofi-translate-bio-to-develop-novel-mrna-vaccine-for-covid-19-disease/ 2020-03-30T07:57:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Corona-4.png https://www.pharmaceutical-business-review.com/news/fda-accepts-roches-nda-for-xofluza-to-treat-influenza-in-children/ 2020-03-30T09:22:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Basel.jpg https://www.pharmaceutical-business-review.com/news/aveo-oncology-and-biodesix-to-discontinue-cyfi-2-study-of-ficlatuzumab-in-aml-in-response-to-public-health-crisis/ 2020-03-30T11:25:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/test-214185_640-2.jpg https://www.pharmaceutical-business-review.com/news/novartis-bmgf-covid-19/ 2020-03-30T12:47:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Corona-2.png https://www.pharmaceutical-business-review.com/news/noveomes-st266-covid-19/ 2020-03-31T09:05:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Corona-5.png https://www.pharmaceutical-business-review.com/news/imfinzi-durvalumab-approved-in-the-us-for-extensive-stage-small-cell-lung-cancer/ 2020-03-31T10:40:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/FDA-drug-evaluation-research-center-1.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-submits-application-for-car-t-therapy-axicabtagene-ciloleucel-to-treat-patients-with-certain-relapsed-refractory-b-cell-lymphomas-in-japan/ 2020-03-31T10:42:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Daichi.jpg https://www.pharmaceutical-business-review.com/news/merck-vericiguat-victoria-trial/ 2020-03-31T12:30:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/science-1336663_640.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-sitryx-immunometabolic/ 2020-04-01T07:51:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Eli-Lilly.jpg https://www.pharmaceutical-business-review.com/news/vbi-vaccines-collaborates-with-the-national-research-council-of-canada-to-develop-pan-coronavirus-vaccine-candidate/ 2020-04-01T09:45:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Epidemic.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-and-bluebird-bio-submit-bla-for-idecabtagene-vicleucel-to-fda/ 2020-04-01T11:15:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/aptorum-repurposed-drugs-coronavirus/ 2020-04-01T12:20:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/covid-19-4927316_640-1.jpg https://www.pharmaceutical-business-review.com/news/concert-pharmaceuticals-announces-plans-for-ctp-543-phase-3-trials-in-alopecia-areata/ 2020-04-02T09:18:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Hairloss.jpg https://www.pharmaceutical-business-review.com/news/beigene-doses-first-patient-in-phase-1b-2-trial-of-zw25-in-her2-positive-breast-cancer-and-gea/ 2020-04-02T11:20:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/laboratory-3827745_640-1.jpg https://www.pharmaceutical-business-review.com/news/tsinghua-brii-bio-covid-19/ 2020-04-03T07:35:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/coronavirus-4833754_640-2.jpg https://www.pharmaceutical-business-review.com/news/amgen-and-adaptive-biotechnologies-announce-strategic-partnership-to-develop-therapeutic-to-prevent-or-treat-covid-19/ 2020-04-03T09:46:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Amgen.jpg https://www.pharmaceutical-business-review.com/news/vir-and-alnylam-expand-collaboration-to-advance-investigational-rnai-therapeutics-targeting-host-factors-for-treatment-of-covid-19/ 2020-04-03T11:36:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/corona-4916954_640.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-acceleron/ 2020-04-06T09:16:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/BMS.jpg https://www.pharmaceutical-business-review.com/news/iveric-bio-announces-fast-track-designation-from-us-fda-for-zimura-to-treat-geographic-atrophy-secondary-to-dry-age-related-macular-degeneration/ 2020-04-06T09:20:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/citius-novellus-covid-19/ 2020-04-06T09:21:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Citrius.png https://www.pharmaceutical-business-review.com/news/shenogen-enters-into-an-exclusive-license-with-bioardis-to-develop-and-commercialise-fgfr4-kinase-inhibitor-for-asian-market/ 2020-04-06T11:40:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/handshake-3298455_640-11.jpg https://www.pharmaceutical-business-review.com/news/novartis-jakavi-covid-19/ 2020-04-06T12:23:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Incyte.jpg https://www.pharmaceutical-business-review.com/news/gsk-vir-biotechnology-coronaviruses/ 2020-04-07T08:37:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Corona-virus.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-second-genome-announce-strategic-collaboration-in-biomarker-and-inflammatory-bowel-disease-drug-discovery/ 2020-04-07T08:40:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Gilead.jpg https://www.pharmaceutical-business-review.com/news/alnylam-and-dicerna-form-rnai-therapeutics-collaboration-on-alpha-1-liver-disease/ 2020-04-07T10:57:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/handshake-3655926_640-3.jpg https://www.pharmaceutical-business-review.com/news/gsk-nucala-synapse-trial-results/ 2020-04-07T11:32:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/1200px-Glaxo_Smith_Kline_Offices_on_the_Great_West_Road_at_Brentford_-_panoramio.jpg https://www.pharmaceutical-business-review.com/news/montreal-heart-institute-covid-19/ 2020-04-08T08:28:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Covid19.jpg https://www.pharmaceutical-business-review.com/news/beam-therapeutics-licenses-sirion-biotechs-lentiboost-technology-for-its-car-t-pipeline/ 2020-04-08T10:45:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/handshake-3298455_640-12.jpg https://www.pharmaceutical-business-review.com/news/cromsource-announces-launch-of-covid-19-clinical-trial/ 2020-04-08T11:11:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/chromsource.jpg https://www.pharmaceutical-business-review.com/news/takeda-alunbrig-alk-nsclc/ 2020-04-08T11:24:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/692px-Takeda-Midosuji-Bldg-01-1.jpg https://www.pharmaceutical-business-review.com/news/alnylam-lumasiran-ph1-approval/ 2020-04-08T11:25:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/FDA-drug-evaluation-research-center.jpg https://www.pharmaceutical-business-review.com/news/oncoimmune-receives-fda-approval-for-covid-19-clinical-trial/ 2020-04-09T08:52:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Immune.jpg https://www.pharmaceutical-business-review.com/news/acceleron-receives-fda-breakthrough-therapy-designation-for-sotatercept-in-pulmonary-arterial-hypertension/ 2020-04-09T11:22:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/FDA-drug-evaluation-research-center-1.jpg https://www.pharmaceutical-business-review.com/news/enzychem-lifesciences-announces-filing-of-us-provisional-patent-for-ec-18-to-treat-covid-19/ 2020-04-13T09:57:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Coronacompound.png https://www.pharmaceutical-business-review.com/news/arrowhead-pharmaceuticals-files-for-regulatory-clearance-to-begin-phase-1-2a-study-of-aro-enac-for-treatment-of-cystic-fibrosis/ 2020-04-13T11:34:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/test-214185_640-3.jpg https://www.pharmaceutical-business-review.com/news/pfizer-braftovi-cetuximab/ 2020-04-13T12:48:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/alnylam-blackstone-rnai-medicines/ 2020-04-14T09:02:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Alnylam.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-koselugo/ 2020-04-14T09:05:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Astra.jpg https://www.pharmaceutical-business-review.com/news/ascletis-receives-ind-approval-for-its-hiv-drug-asc09f/ 2020-04-14T09:45:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Pill.jpg https://www.pharmaceutical-business-review.com/news/ridgeback-biotherapeutics-announces-mhra-clearance-to-begin-human-testing-of-eidd-2801-in-uk-for-covid-19/ 2020-04-14T11:21:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/covid-19-4961257_640-1.jpg https://www.pharmaceutical-business-review.com/news/lilly-baricitinib-covid-19/ 2020-04-14T12:42:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Lilly-corporate-center.jpg https://www.pharmaceutical-business-review.com/news/gsk-sanofi-covid-19/ 2020-04-15T08:51:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/GSK.jpg https://www.pharmaceutical-business-review.com/news/alnylam-receives-fast-track-designation-for-vutrisiran-to-treat-polyneuropathy-of-hattr-amyloidosis/ 2020-04-15T09:37:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/intensity-therapeutics-signs-clinical-collaboration-agreement-with-bristol-myers-squibb-for-advanced-solid-tumors/ 2020-04-15T11:42:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/hope-biosciences-covid-19-stem-cell/ 2020-04-15T12:16:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/coronavirus-4833754_640-3.jpg https://www.pharmaceutical-business-review.com/news/forma-therapeutics-receives-fda-orphan-drug-designation-for-ft-4202-to-treat-sickle-cell-disease/ 2020-04-16T09:51:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/merck-announces-us-launch-of-ontruzant-a-biosimilar-of-herceptin/ 2020-04-16T09:59:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Merck-tablet.jpg https://www.pharmaceutical-business-review.com/news/novartis-tscan-solid-tumours/ 2020-04-17T09:02:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/novartis-tower.jpg https://www.pharmaceutical-business-review.com/news/sinovac-biotech-covid-19-vaccine-trial/ 2020-04-17T09:02:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/syringe-417786_640.jpg https://www.pharmaceutical-business-review.com/news/starpharmas-spl7013-shows-significant-activity-against-sars-cov-2/ 2020-04-17T09:52:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Melborne.jpg https://www.pharmaceutical-business-review.com/news/legochem-biosciences-iksuda-collaborate-to-develop-antibody-drug-conjugates/ 2020-04-17T09:59:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Drugconjugate.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-incytes-pemazyre-as-first-targeted-treatment-for-adults-with-previously-treated-unresectable-locally-advanced-or-metastatic-cholangiocarcinoma/ 2020-04-20T09:11:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/seattle-genetics-tukysa/ 2020-04-20T09:32:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Tukysa.jpg https://www.pharmaceutical-business-review.com/news/revive-therapeutics-partners-with-complete-phytochemical-solutions-to-advance-research-initiatives-for-psilocybin-based-pharmaceutical-products/ 2020-04-20T11:23:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/handshake-3298455_640-19.jpg https://www.pharmaceutical-business-review.com/news/barda-commits-483m-to-moderna-for-covid-19-vaccine/ 2020-04-20T11:57:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Bardavirus.jpg https://www.pharmaceutical-business-review.com/news/novartis-hydroxychloroquine-covid-19/ 2020-04-21T09:20:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Novar.jpg https://www.pharmaceutical-business-review.com/news/ascendis-transcon-pth-hypoparathyroidism/ 2020-04-21T11:14:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/test-214185_640-4.jpg https://www.pharmaceutical-business-review.com/news/wavelength-pharmaceuticals-expands-supplies-of-key-drug-ingredients-for-critically-ill-covid-19-patients/ 2020-04-21T11:20:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/covid-19-4922384_640-7.jpg https://www.pharmaceutical-business-review.com/news/alexion-announces-plans-to-initiate-phase-3-study-of-ultomiris-ravulizumab-cwvz-in-hospitalised-patients-with-severe-covid-19/ 2020-04-21T11:22:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Alex.jpg https://www.pharmaceutical-business-review.com/news/nexus-pharmaceuticals-announces-approval-of-emerphed-injection/ 2020-04-22T09:22:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Emerphed-v1.jpg https://www.pharmaceutical-business-review.com/news/hope-biosciences-announces-third-fda-approved-clinical-trial-for-covid-19/ 2020-04-22T11:04:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/test-214185_640-4-1.jpg https://www.pharmaceutical-business-review.com/news/gilead-onko-innate-nk-cells/ 2020-04-22T11:32:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/cancer-cells-541954_6402.jpg https://www.pharmaceutical-business-review.com/news/opdivo-yervoy-checkmate-743/ 2020-04-22T11:33:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-gets-ec-approval-for-nintedanib-to-treat-ssc-ild/ 2020-04-23T08:40:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Boehngar.jpg https://www.pharmaceutical-business-review.com/news/emergex-signs-agreement-with-george-mason-university-for-highly-pathogenic-rna-virus-studies/ 2020-04-23T09:11:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/University.jpg https://www.pharmaceutical-business-review.com/news/akili-announces-endeavor-digital-attention-treatment-is-available-for-children-with-adhd-under-fdas-covid-19-enforcement-discretion-guidance/ 2020-04-23T11:12:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Endeavor_1.jpg https://www.pharmaceutical-business-review.com/news/agastiya-biotech-proceeding-with-drug-candidate-for-covid-19/ 2020-04-24T09:18:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/corvirus.jpg https://www.pharmaceutical-business-review.com/news/novartis-kymriah-follicular-lymphoma/ 2020-04-24T09:29:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Novartis-tower-1.jpg https://www.pharmaceutical-business-review.com/news/affinivax-announces-120m-series-b-financing-to-advance-pipeline-of-novel-maps-vaccines-and-immunotherapies/ 2020-04-24T11:20:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/syringe-1884758_640.jpg https://www.pharmaceutical-business-review.com/news/sanofi-menquadfi-menquadfi-vaccine/ 2020-04-27T09:21:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Meningo.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-covid-19-farxiga/ 2020-04-27T09:23:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Astraglobe.jpg https://www.pharmaceutical-business-review.com/news/janssen-announces-submission-of-two-applications-to-us-fda-seeking-approval-of-simponi-aria-to-treat-polyarticular-juvenile-idiopathic-arthritis-and-juvenile-psoriatic-arthritis/ 2020-04-27T10:25:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/JandJ.jpg https://www.pharmaceutical-business-review.com/news/verastem-oncology-announces-preliminary-data-from-investigator-initiated-study-highlighting-clinical-activity-of-raf-mek-and-fak-combination-in-kras-mutant-tumors/ 2020-04-27T11:37:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/science-1336663_640-1.jpg https://www.pharmaceutical-business-review.com/news/takeda-mobocertinib-nsclc/ 2020-04-28T09:20:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Takeda.jpg https://www.pharmaceutical-business-review.com/news/moderna-announces-ind-submitted-to-us-fda-for-phase-2-study-of-mrna-1273-against-novel-coronavirus/ 2020-04-28T10:32:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Moderna.jpg https://www.pharmaceutical-business-review.com/news/lynparza-profound-trial-os-benefit/ 2020-04-28T11:19:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Lynparza-e1539707982100.jpg https://www.pharmaceutical-business-review.com/news/merck-and-institute-for-systems-biology-collaborate-to-define-molecular-mechanisms-of-sars-cov-2-infection-and-identify-potential-prognostic-biomarkers/ 2020-04-28T11:23:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/virus-4835301_640-2.jpg https://www.pharmaceutical-business-review.com/news/novartis-canakinumab-pneumonia/ 2020-04-29T09:06:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Novar-1.jpg https://www.pharmaceutical-business-review.com/news/quotient-sciences-and-cytoagents-accelerate-potential-treatment-for-covid-19-cytokine-storm/ 2020-04-29T09:15:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Cytokinen.jpg https://www.pharmaceutical-business-review.com/news/affinia-vertex-aav-capsids-deal/ 2020-04-29T10:58:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/dna-1811955_640.jpg https://www.pharmaceutical-business-review.com/news/ocular-therapeutix-announces-topline-results-of-phase-3-trial-of-dextenza-for-treatment-of-ocular-itching-associated-with-allergic-conjunctivitis/ 2020-04-29T11:07:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/lab-3498584_640-1.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-zejula-in-platinum-responsive-advanced-ovarian-cancer-regardless-of-biomarker-status/ 2020-04-30T11:06:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/catalent-signs-agreement-with-johnson-johnson-to-be-us-manufacturing-partner-for-lead-covid-19-vaccine-candidate/ 2020-04-30T11:50:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/CCC.png https://www.pharmaceutical-business-review.com/news/gilead-remdesivir/ 2020-05-01T09:15:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Gileadcovid.jpg https://www.pharmaceutical-business-review.com/news/keytruda-400mg-fda-approval/ 2020-05-01T09:15:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine-against-novel-coronavirus/ 2020-05-01T10:16:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/corvirus.jpg https://www.pharmaceutical-business-review.com/news/banner-life-sciences-announces-final-fda-approval-of-bafiertam-for-multiple-sclerosis/ 2020-05-01T11:39:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/canada-abcellera-covid-19/ 2020-05-04T09:31:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Covidvirus.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-oxford-university-covid-19/ 2020-05-04T10:33:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Astravirus.jpg https://www.pharmaceutical-business-review.com/news/fda-accepts-for-priority-review-bristol-myers-squibbs-application-for-cc-486-for-maintenance-treatment-of-adults-in-remission-with-aml/ 2020-05-04T10:41:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/novartis-receives-chmp-positive-opinion-for-enerzair-breezhaler/ 2020-05-04T11:21:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/novartis.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-junshi-covid-19/ 2020-05-05T09:47:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Junishi.jpg https://www.pharmaceutical-business-review.com/news/arcturus-therapeutics-catalent-announce-partnership-to-manufacture-mrna-based-covid-19-vaccine/ 2020-05-05T10:51:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/catalent.png https://www.pharmaceutical-business-review.com/news/vir-2703-covid-19-rnai-therapeutic/ 2020-05-05T11:08:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/covid-19-4982910_640-4.jpg https://www.pharmaceutical-business-review.com/news/acceleron-receives-prime-designation-from-ema-for-sotatercept-in-pulmonary-arterial-hypertension/ 2020-05-05T11:13:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/laboratory-3827745_640-2.jpg https://www.pharmaceutical-business-review.com/news/lineage-cell-therapeutics-to-apply-allogeneic-dendritic-cell-therapy-programme-to-covid-19-vaccine-development/ 2020-05-06T09:28:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/corden.jpg https://www.pharmaceutical-business-review.com/news/alexion-portola-biopharmaceutical/ 2020-05-06T10:06:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Alexion.jpg https://www.pharmaceutical-business-review.com/news/bicycle-therapeutics-announces-first-patient-dosed-in-phase-i-dose-escalation-of-bt5528-in-combination-with-nivolumab/ 2020-05-06T11:04:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/blood-20745_640-1.jpg https://www.pharmaceutical-business-review.com/news/twist-bioscience-identifies-competitive-antibodies-for-sars-cov-2/ 2020-05-07T11:06:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Twist.jpg https://www.pharmaceutical-business-review.com/news/laurent-pharmaceuticals-receives-health-canadas-approval-to-initiate-covid-19-clinical-trial/ 2020-05-07T11:19:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/coronavirus-4972480_640-6.jpg https://www.pharmaceutical-business-review.com/news/novartis-tabrecta-nsclc/ 2020-05-08T09:05:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Novarbuilding.jpg https://www.pharmaceutical-business-review.com/news/covid-19-vaccine-candidate-bnt162-trial/ 2020-05-08T09:05:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/certara-and-dmtc-announce-research-collaboration-to-study-preventative-use-of-chloroquine-in-health-care-workers-at-high-risk-for-covid-19/ 2020-05-08T10:07:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/STBT.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-submits-snda-for-trastuzumab-deruxtecan-in-japan-for-her2-positive-metastatic-gastric-cancer/ 2020-05-08T10:57:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/cancer-cells-541954_640.jpg https://www.pharmaceutical-business-review.com/news/lilly-receives-us-fda-approval-for-retevmo/ 2020-05-11T10:43:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Eli-Lilly.jpg https://www.pharmaceutical-business-review.com/news/ec-approves-subcutaneous-formulation-of-entyvio-as-maintenance-therapy-in-ulcerative-colitis-or-crohns-disease/ 2020-05-11T10:52:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Takeda.jpg https://www.pharmaceutical-business-review.com/news/zyus-vido-intervac/ 2020-05-11T11:30:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Covid-19-disease.png https://www.pharmaceutical-business-review.com/news/india-glenmark-covid-19/ 2020-05-12T08:33:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Glenmark.png https://www.pharmaceutical-business-review.com/news/astrazeneca-daiichi-sankyo-enhertu/ 2020-05-12T08:34:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/drug.jpg https://www.pharmaceutical-business-review.com/news/crispr-therapeutics-and-vertex-pharmaceuticals-announce-fda-rmat-designation-granted-to-ctx001-to-treat-severe-hemoglobinopathies/ 2020-05-12T10:01:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/appili-therapeutics-submits-cta-with-health-canada-to-sponsor-trial-of-favipiravir-as-preventative-measure-against-covid-19/ 2020-05-12T10:11:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/covid-19-4961257_640-8.jpg https://www.pharmaceutical-business-review.com/news/jcyte-santen-jcell-deal/ 2020-05-12T12:05:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/1200px-Santen_Pharmaceutical_Co._Ltd._Nara_RD_Center_3.jpg https://www.pharmaceutical-business-review.com/news/moderna-mrna-vaccine/ 2020-05-13T08:54:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/coronaModerna.jpg https://www.pharmaceutical-business-review.com/news/ocular-therapeutix-announces-first-patient-dosed-in-phase-1-clinical-trial-of-otx-csi-to-treat-dry-eye-disease/ 2020-05-13T09:52:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Eye.jpg https://www.pharmaceutical-business-review.com/news/acer-therapeutics-emetine-covid-19/ 2020-05-13T11:16:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/covid-19-4982910_640-5.jpg https://www.pharmaceutical-business-review.com/news/seattle-genetics-gets-approval-of-tukysa-in-switzerland-for-metastatic-her2-positive-breast-cancer/ 2020-05-13T11:21:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/cancer-cells-541954_640-1.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-collaborates-with-cdr-life-to-develop-antibody-fragment-based-therapeutics-for-geographic-atrophy/ 2020-05-14T10:38:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/geography.jpg https://www.pharmaceutical-business-review.com/news/cipla-enters-into-a-licensing-agreement-with-gilead-to-expand-access-to-covid-19-treatment/ 2020-05-14T11:18:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/coronavirus-4972480_640-7.jpg https://www.pharmaceutical-business-review.com/news/sanofi-sarclisa-ikema-trial/ 2020-05-15T09:31:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/1200px-Sanofi_Frankfurt_IPH.jpg https://www.pharmaceutical-business-review.com/news/neuraptive-therapeutics-announces-fda-has-granted-fast-track-designation-to-ntx-001-clinical-development-programme-to-treat-peripheral-nerve-injuries/ 2020-05-15T09:59:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/nantkwest-and-immunitybio-to-initiate-a-phase-2-study-of-immunotherapy-for-metastatic-pancreatic-cancer/ 2020-05-15T10:53:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/science-1336663_640-2.jpg https://www.pharmaceutical-business-review.com/news/catalent-ennaid-therapeutics-covid-19/ 2020-05-18T09:15:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Covid-disease.jpg https://www.pharmaceutical-business-review.com/news/can-fite-announces-pre-ind-submission-to-us-fda-for-piclidenoson-in-treatment-of-covid-19-infected-patients-with-moderate-to-severe-symptoms/ 2020-05-18T10:11:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Pr-ind.jpg https://www.pharmaceutical-business-review.com/news/deciphera-qinlock-gastrointestinal/ 2020-05-19T09:05:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/takeda-lymphoma-adcetris/ 2020-05-19T09:06:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Takeda.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-genentechs-tecentriq-as-first-line-monotherapy-for-certain-people-with-metastatic-nsclc/ 2020-05-19T10:29:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/novartis-avexis-gets-zolgensma/ 2020-05-20T09:03:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Novarbuilding-1.jpg https://www.pharmaceutical-business-review.com/news/moderna-covid-19-vaccine/ 2020-05-20T09:04:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Moderna.jpg https://www.pharmaceutical-business-review.com/news/rallybio-series-b-round/ 2020-05-20T11:14:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/science-1029385_640-1.jpg https://www.pharmaceutical-business-review.com/news/janssen-announces-phase-1-results-for-amivantamab-in-advanced-nsclc-harbouring-exon-20-insertion-mutations/ 2020-05-20T11:22:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/laboratory-3827745_640-3.jpg https://www.pharmaceutical-business-review.com/news/tolero-pharmaceuticals-submits-investigational-new-drug-application-for-experimental-pkm2-activator-tp-1454/ 2020-05-20T11:27:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/lynparza-approved-in-us-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/ 2020-05-21T09:29:41+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-usa-ind-covid-19/ 2020-05-21T09:29:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Octapharma.jpg https://www.pharmaceutical-business-review.com/news/gilead-and-galapagos-announce-positive-topline-results-of-phase-2b-3-trial-of-filgotinib-in-moderately-to-severely-active-ulcerative-colitis/ 2020-05-21T11:15:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/test-214185_640-6.jpg https://www.pharmaceutical-business-review.com/news/sunovion-kynmobi-parkinsons/ 2020-05-22T09:10:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Kynobi.jpg https://www.pharmaceutical-business-review.com/news/nautilus-biotechnology-raises-76m-in-series-b-funding-to-be-first-to-quantify-human-proteome/ 2020-05-22T10:42:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Nautis.jpg https://www.pharmaceutical-business-review.com/news/antisense-atl1102-final-phase-2-dmd-results-meet-primary-endpoint-and-exceed-expectations-on-secondary-endpoints/ 2020-05-22T11:22:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/science-1336663_640-3.jpg https://www.pharmaceutical-business-review.com/news/enhertu-granted-orphan-drug-designation-in-us-for-gastric-cancer/ 2020-05-26T09:21:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-6.jpg https://www.pharmaceutical-business-review.com/news/algernon-ifenprodil-covid-19/ 2020-05-26T09:29:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Ifendriol.jpg https://www.pharmaceutical-business-review.com/news/appili-therapeutics-favipiravir-canada-trial/ 2020-05-26T11:30:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/covid-19-4922384_640-10.jpg https://www.pharmaceutical-business-review.com/news/us-fda-approves-takedas-alunbrig-for-rare-and-serious-form-of-lung-cancer/ 2020-05-26T11:34:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Takeda.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-dupixent-as-first-biologic-medicine-for-children-aged-six-to-11-years-with-moderate-to-severe-atopic-dermatitis/ 2020-05-27T08:56:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-7.jpg https://www.pharmaceutical-business-review.com/news/shionogi-tetra-therapeutics/ 2020-05-27T09:13:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Thermo.jpg https://www.pharmaceutical-business-review.com/news/novaremed-nrd135s-e1-fda-ind/ 2020-05-27T11:26:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/lab-3498584_640-2.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-opdivo-yervoy-combined-with-limited-chemotherapy-as-first-line-treatment-of-metastatic-or-recurrent-nsclc/ 2020-05-27T11:33:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/phasebio-vip-receptor-pb1046/ 2020-05-28T08:55:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Pharmacorona.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-of-nucala-for-patients-with-hypereosinophilic-syndrome/ 2020-05-28T09:35:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/GSK.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-receives-ec-approval-for-zeposia-in-adults-with-rrms-with-active-disease/ 2020-05-28T11:03:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/merck-themis-bioscience-acquisition/ 2020-05-28T12:10:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/vaccine-5074670_640.jpg https://www.pharmaceutical-business-review.com/news/bird-rock-bio-files-ind-application-for-phase-2-study-of-nimacimab-for-treatment-of-renal-diseases/ 2020-05-29T07:01:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-6.jpg https://www.pharmaceutical-business-review.com/uncategorized/sab-biotherapeutics-confirms-neutralising-antibodies-to-sars-cov-2-and-begins-clinical-manufacturing-of-novel-covid-19-therapeutic-candidate/ 2020-05-29T10:32:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/SAB.png https://www.pharmaceutical-business-review.com/news/gilead-sciences-arcus-biosciences-deal/ 2020-06-01T06:23:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/cancer-cells-541954_640-2.jpg https://www.pharmaceutical-business-review.com/news/imfinzi-shows-sustained-os-benefit-in-first-line-es-sclc-in-caspian-trial/ 2020-06-01T11:22:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/gilead-remdesivir-eua-covid-19/ 2020-06-02T09:54:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/coronavirus-4972480_640-4.jpg https://www.pharmaceutical-business-review.com/news/roche-covid-19-pneumonia/ 2020-06-02T10:07:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Pneumonia.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-heart-disease-brilinta/ 2020-06-02T10:26:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Gaithusberg.jpg https://www.pharmaceutical-business-review.com/news/codiak-biosciences-collaborates-with-ragon-institute-to-evaluate-exovacc-vaccine-platform-in-sars-cov-2-and-hiv/ 2020-06-02T10:34:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Institute.jpg https://www.pharmaceutical-business-review.com/news/genentech-tecentriq-avastin-fda/ 2020-06-02T10:59:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/1210314-e1590992478300.jpg https://www.pharmaceutical-business-review.com/news/aveo-oncology-announces-fda-acceptance-for-filing-of-an-nda-for-tivozanib-as-treatment-of-relapsed-or-refractory-renal-cell-carcinoma/ 2020-06-02T11:02:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-7.jpg https://www.pharmaceutical-business-review.com/news/fsd-pharma-covid-19/ 2020-06-03T09:11:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/FSD-Pharma.jpg https://www.pharmaceutical-business-review.com/news/agex-therapeutics-imstem-biotechnology-sign-non-binding-letter-of-intent-regarding-investigational-msc-candidate-ims001-for-covid-19/ 2020-06-03T09:43:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Resume.png https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-announces-positive-topline-results-from-true-north-trial-evaluating-zeposia-in-ulcerative-colitis/ 2020-06-03T11:12:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/sanofi-sarclisa-ec-approval/ 2020-06-03T11:40:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/1200px-Sanofi_Frankfurt_IPH-1.jpg https://www.pharmaceutical-business-review.com/news/octapharma-usa-extends-funding-for-covid-19-study-following-positive-preliminary-research-data/ 2020-06-04T08:51:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Octpharm.jpg https://www.pharmaceutical-business-review.com/news/pierre-fabre-braftovi-cetuximab/ 2020-06-04T09:18:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/EC-building.jpg https://www.pharmaceutical-business-review.com/news/janssens-tremfya-delivers-improvement-in-psoriatic-arthritis-joint-and-skin-symptoms-at-week-52-in-phase-3-trials/ 2020-06-04T11:05:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Johnson.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-accent-cancer/ 2020-06-05T08:46:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Astra-scaled.jpg https://www.pharmaceutical-business-review.com/uncategorized/memo-therapeutics-identifies-potent-sars-cov-2-neutralising-antibodies-from-blood-of-recovered-covid-19-patients/ 2020-06-05T09:24:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Antibody.jpg https://www.pharmaceutical-business-review.com/news/cullinan-oncology-completes-98-5m-series-b-financing/ 2020-06-05T10:53:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/cancer-cells-541954_640-3.jpg https://www.pharmaceutical-business-review.com/news/calquence-showed-promising-clinical-improvement-in-majority-of-19-hospitalised-covid-19-patients/ 2020-06-08T09:03:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Catalyse.jpg https://www.pharmaceutical-business-review.com/news/merck-recarbrio-habp-vabp/ 2020-06-08T09:14:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/alnylam-presents-positive-phase-3-results-from-illuminate-a-study-of-lumasiran/ 2020-06-08T11:09:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/test-214185_640-7.jpg https://www.pharmaceutical-business-review.com/news/janssen-daratumumab-subcutaneous-ec/ 2020-06-08T11:52:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/darzalex-product-shot-1022x1024-1.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-junshi-covid-19-trial/ 2020-06-09T08:54:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Junishi.jpg https://www.pharmaceutical-business-review.com/news/relief-therapeutics-and-neurorx-expand-clinical-trial-of-rlf-100-to-all-patients-with-critical-covid-19-and-respiratory-failure/ 2020-06-09T10:54:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Trial.jpg https://www.pharmaceutical-business-review.com/news/algotherapeutix-announces-orphan-drug-designation-granted-by-fda-for-atx01-in-erythromelalgia/ 2020-06-09T11:01:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/1200px-Erythromelalgia-symptoms.jpg https://www.pharmaceutical-business-review.com/news/igy-life-sciences-mms-covid-19-antibody/ 2020-06-09T11:31:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/covid-19-4982910_640-8.jpg https://www.pharmaceutical-business-review.com/news/abbvie-antibody-therapeutic-covid-19/ 2020-06-09T11:32:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/abbvie-hq.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-ubivac/ 2020-06-10T10:34:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/BMS-facility.jpg https://www.pharmaceutical-business-review.com/news/lyvgen-announces-clinical-trial-collaboration-with-msd/ 2020-06-10T10:36:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Lab.jpg https://www.pharmaceutical-business-review.com/news/autobahn-therapeutics-launches-with-76m-series-b-financing-to-develop-next-generation-therapies-for-cns-disorders/ 2020-06-10T11:15:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/dollar-2891817_640-1.jpg https://www.pharmaceutical-business-review.com/news/fujifilm-denmark-biologics-production-facility/ 2020-06-11T09:25:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/1200px-Tokyo_Midtown_West.jpg https://www.pharmaceutical-business-review.com/news/pfizer-announces-positive-top-line-results-from-jade-teen-trial-of-abrocitinib-in-adolescents-with-moderate-to-severe-atopic-dermatitis/ 2020-06-11T09:54:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/clovis-oncology-completes-target-enrollment-in-athena-trial-in-advanced-ovarian-cancer/ 2020-06-11T11:02:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/cancer-cells-541954_640-4.jpg https://www.pharmaceutical-business-review.com/news/leap-therapeutics-announces-orphan-drug-designation-of-dkn-01-for-the-treatment-of-gastric-and-gastroesophageal-junction-cancer/ 2020-06-12T11:09:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/FDA-drug-7.jpg https://www.pharmaceutical-business-review.com/news/novo-nordisk-acquire-corvidia/ 2020-06-15T06:37:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/image.jpg https://www.pharmaceutical-business-review.com/news/vertex-kalydeco-cystic-fibrosis/ 2020-06-15T06:37:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/EC-building-1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-to-supply-europe-with-up-to-400-million-doses-of-oxford-universitys-vaccine-at-no-profit/ 2020-06-15T11:18:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Gaithusberg.jpg https://www.pharmaceutical-business-review.com/news/neoimmunetech-receives-fda-orphan-drug-designation-for-nt-i7-to-treat-progressive-multifocal-leukoencephalopathy/ 2020-06-16T10:02:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/fda-approval-dolutegravir-dispersible-tablet/ 2020-06-16T10:39:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/hiv-1903372_640-1.jpg https://www.pharmaceutical-business-review.com/news/sc-formulation-of-darzalex-combination-delivers-deep-and-rapid-haematologic-responses-and-improved-clinical-outcomes-in-newly-diagnosed-light-chain-amyloidosis/ 2020-06-16T10:49:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/darzalex-product-shot-1022x1024-1.jpg https://www.pharmaceutical-business-review.com/news/merck-and-pfizers-sglt2-inhibitor-steglatro-meets-primary-endpoint-in-vertis-cv-trial/ 2020-06-17T07:29:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/takeda-neurocrine-psychiatric-disorders/ 2020-06-17T07:30:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Takeda.jpg https://www.pharmaceutical-business-review.com/news/ideaya-and-gsk-announce-a-broad-partnership-in-synthetic-lethality/ 2020-06-17T10:53:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/GSK.jpg https://www.pharmaceutical-business-review.com/news/interdisciplinary-consortium-receives-grant-to-develop-next-generation-cell-based-cancer-vaccines/ 2020-06-18T10:36:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Optimised.jpg https://www.pharmaceutical-business-review.com/news/epizyme-announces-us-fda-accelerated-approval-of-tazverik-for-relapsed-refractory-follicular-lymphoma/ 2020-06-19T11:40:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Tazverik.jpg https://www.pharmaceutical-business-review.com/news/takeda-to-divest-otc-and-select-non-core-assets-in-asia-pacific-to-celltrion-for-up-to-278m/ 2020-06-21T18:09:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Takeda-1.jpg https://www.pharmaceutical-business-review.com/news/roche-tecentriq-breast-cancer/ 2020-06-22T06:27:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Roche.jpg https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-spondyloarthritis/ 2020-06-22T06:27:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Novartis.jpg https://www.pharmaceutical-business-review.com/news/deciphera-announces-health-canadas-authorization-of-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumour/ 2020-06-23T11:35:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/cancer-cells-541954_640-5.jpg https://www.pharmaceutical-business-review.com/news/piramal-pharma-solutions-announces-acquisition-of-solid-oral-dosage-drug-product-facility-in-sellersville-pennsylvania-from-gw-laboratories/ 2020-06-23T11:39:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/piramal-facility.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-pionyr-immunotherapeutics/ 2020-06-24T05:04:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Gileadscience.jpg https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-translate-bio-mrna-vaccines/ 2020-06-24T11:08:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/medical-5037940_640.jpg https://www.pharmaceutical-business-review.com/news/merck-v114-phase-3-trials/ 2020-06-24T11:10:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/laboratory-3827745_640-4.jpg https://www.pharmaceutical-business-review.com/news/novaremed-gets-fda-nod-for-phase-2-trial-of-nrd135s-e1-for-pdpn/ 2020-06-24T11:19:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/test-214185_640-8.jpg https://www.pharmaceutical-business-review.com/news/frontier-scientific-develops-and-provides-process-to-produce-active-pharmaceutical-ingredient-for-clinical-trial-of-covid-19-therapeutic-investigational-drug-rbt-9/ 2020-06-24T11:20:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Frontier.jpg https://www.pharmaceutical-business-review.com/news/cipla-remdesivir-covid-19/ 2020-06-24T11:22:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Cipla.jpg https://www.pharmaceutical-business-review.com/news/covid-19-india-favipiravir-remdesivir/ 2020-06-24T11:22:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/corona-5174671_640-1.jpg https://www.pharmaceutical-business-review.com/news/sanofi-france-vaccines-investment/ 2020-06-24T11:22:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/injection-5051142_640.jpg https://www.pharmaceutical-business-review.com/news/jazz-pharmamar-zepzelca-fda/ 2020-06-24T11:22:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Zepzelca.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-covid-19-baricitinib/ 2020-06-24T11:23:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Eli-Lilly.jpg https://www.pharmaceutical-business-review.com/news/symbiosis-and-astrazeneca-sign-supply-agreement-for-sterile-manufacture-of-covid-19-vaccine-for-clinical-trials/ 2020-06-25T09:59:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Symbiosis.jpg https://www.pharmaceutical-business-review.com/news/pt010-significantly-reduced-rate-of-moderate-or-severe-copd-exacerbations-in-ethos-trial/ 2020-06-25T11:26:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Astra.jpg https://www.pharmaceutical-business-review.com/news/aadi-bioscience-initiates-rolling-submission-of-nda-to-fda-for-nab-sirolimus-for-advanced-malignant-pecoma/ 2020-06-26T11:05:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/moderna-and-catalent-announce-collaboration-for-fill-finish-manufacturing-of-modernas-covid-19-vaccine-candidate/ 2020-06-29T00:42:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/cor.jpg https://www.pharmaceutical-business-review.com/news/theravance-biopharma-covid-19/ 2020-06-29T06:28:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Jaki.jpg https://www.pharmaceutical-business-review.com/news/neurorx-relief-therapeutics-covid-19/ 2020-06-29T06:28:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Neurotryx.jpg https://www.pharmaceutical-business-review.com/news/ec-approves-reblozyl-for-transfusion-dependent-anemia-in-myelodysplastic-syndromes-or-beta-thalassemia/ 2020-06-29T07:00:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/roche-phesgo-breast-cancer/ 2020-06-30T08:10:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Basel-1.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-mercks-keytruda-for-first-line-treatment-of-patients-with-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer/ 2020-06-30T11:09:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/health-canada-approves-phase-2a-covid-19-trial-of-nuvoxs-oxygen-therapeutic/ 2020-06-30T11:28:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/covid-19-4982910_640-9.jpg https://www.pharmaceutical-business-review.com/news/carlyle-group-piramal-pharma-deal/ 2020-06-30T11:29:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/job-4131482_640-19.jpg https://www.pharmaceutical-business-review.com/news/goldfinch-bio-series-b-round/ 2020-07-01T11:28:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/job-4131482_640-20.jpg https://www.pharmaceutical-business-review.com/news/pfizer-daurismo-leukaemia/ 2020-07-01T11:29:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/gsk-duvroq-japan-anaemia-ckd/ 2020-07-01T11:29:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/GSK-londo.jpg https://www.pharmaceutical-business-review.com/news/exelixis-initiates-phase-3-trial-of-cabozantinib-atezolizumab-combo-in-prostate-cancer/ 2020-07-01T11:35:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/test-214185_640-9.jpg https://www.pharmaceutical-business-review.com/news/oncternal-therapeutics-gets-fda-orphan-drug-designations-for-cirmtuzumab-ror1-antibody-to-treat-mcl-and-cll/ 2020-07-01T11:37:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-announce-early-positive-data-from-sars-cov-2-trial/ 2020-07-02T10:24:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/corona-trial.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-expands-ds-1062-study-to-include-patients-with-triple-negative-breast-cancer/ 2020-07-02T11:06:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/1200px-Daiichi_Sankyo_Nihonbashi_Building_at_Nihonbashi_Chuo_Tokyo_2019-01-02_03.jpg https://www.pharmaceutical-business-review.com/news/kkr-to-acquire-controlling-stake-in-j-b-chemicals-pharmaceuticals/ 2020-07-03T09:15:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/JB-Pharma.jpg https://www.pharmaceutical-business-review.com/news/eusa-pharma-gets-fda-nod-for-phase-3-covid-19-trial-for-siltuximab/ 2020-07-03T11:23:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-veklury/ 2020-07-06T08:50:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Gilead.jpg https://www.pharmaceutical-business-review.com/news/janssen-ebola-vaccine-regimen/ 2020-07-06T09:23:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Ebola.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-rukobia/ 2020-07-06T10:42:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Rukobia.jpg https://www.pharmaceutical-business-review.com/news/idorsia-announces-positive-results-in-second-phase-3-study-of-daridorexant/ 2020-07-06T10:47:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/laboratory-3827736_640-1.jpg https://www.pharmaceutical-business-review.com/news/ema-grants-accelerated-assessment-for-trastuzumab-deruxtecan-to-treat-her2-positive-metastatic-breast-cancer/ 2020-07-06T11:22:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Pill.jpg https://www.pharmaceutical-business-review.com/news/regeneron-covid-19-double-antibody/ 2020-07-07T08:44:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/CovidRegeneron.jpg https://www.pharmaceutical-business-review.com/news/sinovac-covid-19-vaccine-collaboration-with-butantan-receives-approval-from-brazilian-regulator-for-phase-iii-trial/ 2020-07-07T10:06:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Trial.jpg https://www.pharmaceutical-business-review.com/news/ascentage-msd-apg-115-keytruda/ 2020-07-07T10:54:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Keytruda-scaled-e1594032023890.jpg https://www.pharmaceutical-business-review.com/news/vrobio-announces-new-patients-dosed-in-gaucher-disease-and-cystinosis-trials/ 2020-07-07T10:58:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/laboratory-2815631_640.jpg https://www.pharmaceutical-business-review.com/news/corvus-clinical-trial-immunotherapy/ 2020-07-08T08:39:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Corvus.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-neurogenes-gene-therapy-for-treatment-of-cln5-batten-disease/ 2020-07-08T09:56:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/sunovion-sep-4199-bipolar-i-depression/ 2020-07-08T10:23:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/test-214185_640-10.jpg https://www.pharmaceutical-business-review.com/news/vor-biopharma-closes-110m-series-b-financing/ 2020-07-08T10:28:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/dollar-499481_640.jpg https://www.pharmaceutical-business-review.com/news/concert-receives-fda-breakthrough-status-for-ctp-543-in-alopecia-areata/ 2020-07-09T10:53:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/moderna-completes-enrolment-of-phase-2-study-of-its-mrna-vaccine-against-covid-19/ 2020-07-09T11:01:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Cvid.png https://www.pharmaceutical-business-review.com/news/noxopharm-reports-covid-19-trial-programme-to-commence-in-europe/ 2020-07-10T06:52:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Virus.jpg https://www.pharmaceutical-business-review.com/news/ridgeback-eidd-2801-covid-19-phase-2/ 2020-07-10T09:04:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/agile.jpg https://www.pharmaceutical-business-review.com/news/kymera-therapeutics-sanofi-collaborate-to-advance-novel-protein-degrader-therapies-to-patients/ 2020-07-10T10:21:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Sanofidrug.jpg https://www.pharmaceutical-business-review.com/news/pfizer-ntimicrobial-resistance/ 2020-07-13T06:49:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Pfizer-1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-lynparza/ 2020-07-13T06:50:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Astra-scaled.jpg https://www.pharmaceutical-business-review.com/news/merck-opens-largest-m-lab-collaboration-centre-in-shanghai/ 2020-07-13T11:36:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Merck-M-Lab-scaled.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-fda-fast-track-status/ 2020-07-14T09:32:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/sechenov-coronavirus-vaccine-candidate-trials/ 2020-07-14T09:33:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/syringe-417786_640-1.jpg https://www.pharmaceutical-business-review.com/news/rocket-pharmaceuticals-treats-first-patient-in-phase-1-trial-of-rp-l301-for-pkd/ 2020-07-14T10:54:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/dna-5297378_640.jpg https://www.pharmaceutical-business-review.com/news/glenmark-commences-1000-patients-post-marketing-surveillance-study-with-covid-19-who-are-administered-fabiflu/ 2020-07-14T10:55:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Glenmark.jpg https://www.pharmaceutical-business-review.com/news/medicago-covid-19-vaccine/ 2020-07-15T09:48:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Covid-19.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-for-inflazomes-inzomelid-to-treat-cryopyrin-associated-periodic-syndromes/ 2020-07-15T10:25:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/60-degrees-announces-positive-results-of-cell-culture-testing-of-arakoda-for-covid-19/ 2020-07-15T11:01:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/corona-5174671_640-2.jpg https://www.pharmaceutical-business-review.com/news/roche-blueprint-medicines-pralsetinib/ 2020-07-15T11:39:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Roche-headquarters.jpg https://www.pharmaceutical-business-review.com/news/us-university-says-common-fda-approved-drug-may-effectively-neutralise-sars-cov-2-virus/ 2020-07-16T11:11:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/COVID.jpg https://www.pharmaceutical-business-review.com/news/bioaegis-therapeutics-receives-approval-to-proceed-with-phase-2-trial-of-its-gelsolin-covid-19-treatment/ 2020-07-16T11:56:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Genoris.jpg https://www.pharmaceutical-business-review.com/news/boehringer-nintedanib-ipulmonary-fibrosis/ 2020-07-17T07:29:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Boehnger.jpg https://www.pharmaceutical-business-review.com/news/janssen-tremfya-active-psoriatic-arthritis-fda/ 2020-07-17T07:30:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Tremfya-e1544686766749.jpg https://www.pharmaceutical-business-review.com/news/novartis-not-for-profit-medicines-covid-19/ 2020-07-17T07:37:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/tower-with-surrounding-buildings-image-scaled.jpg https://www.pharmaceutical-business-review.com/news/brilinta-significantly-reduced-rate-of-composite-of-stroke-and-death-in-thales-trial/ 2020-07-17T10:17:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Astra.jpg https://www.pharmaceutical-business-review.com/news/tonix-announces-collaboration-to-develop-precision-medicine-techniques-for-covid-19-vaccines-and-therapeutics/ 2020-07-17T10:35:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/vaccine-4946480_640.jpg https://www.pharmaceutical-business-review.com/news/lillys-mirikizumab-superior-to-cosentyx-in-phase-3-study-for-patients-with-moderate-to-severe-plaque-psoriasis/ 2020-07-20T10:51:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Lilly.jpg https://www.pharmaceutical-business-review.com/news/adc-therapeutics-begins-phase-2-portion-of-lotis-3-trial-of-lonca-ibrutinibhave-combo/ 2020-07-20T11:05:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/cancer-cells-541954_640-6.jpg https://www.pharmaceutical-business-review.com/news/sinopharm-covid-19-inactivated-vaccine/ 2020-07-20T17:53:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/HE_Sheikh_Abdullah_bin_Mohammed_Al_Hamed_Chairman_of_Department_of_Health.jpg https://www.pharmaceutical-business-review.com/news/celltrion-covid-19-antiviral/ 2020-07-20T17:53:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Cellitron.jpg https://www.pharmaceutical-business-review.com/news/azd1222-astrazeneca-oxford-trial/ 2020-07-21T10:08:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/AstraZeneca-headquarters.jpg https://www.pharmaceutical-business-review.com/news/jw-therapeutics-acquires-syracuse-and-license-to-eurekas-solid-tumour-technology-in-china/ 2020-07-21T10:46:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/handshake-3298455_640-41.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-announce-agreement-with-uk-for-30-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2/ 2020-07-21T10:56:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Biontech.jpg https://www.pharmaceutical-business-review.com/news/aurinia-announces-fda-acceptance-of-nda-filing-and-priority-review-for-voclosporin-to-treat-lupus-nephritis/ 2020-07-22T09:39:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/jnana-roche-small-molecule-drugs/ 2020-07-22T10:26:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Roche-Switzerland-headquarters.jpg https://www.pharmaceutical-business-review.com/news/gsk-curevac-mrna-technology/ 2020-07-22T10:28:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/GSK-house.jpg https://www.pharmaceutical-business-review.com/news/xylocor-doses-patients-in-phase-1-2-trial-evaluating-xc001-in-refractory-angina/ 2020-07-22T10:33:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/dna-5297378_640-1.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-tizona-therapeutics/ 2020-07-23T10:51:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Gilead-1.jpg https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-gets-us-fda-approval-of-xywav-for-cataplexy-associated-with-narcolepsy/ 2020-07-23T10:58:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/jazz-scaled.jpg https://www.pharmaceutical-business-review.com/news/medidata-supports-modernas-covid-19-vaccine-clinical-trials-with-rave-clinical-cloud-platform/ 2020-07-24T10:33:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Medi.jpg https://www.pharmaceutical-business-review.com/news/inotrem-gets-clearance-to-launch-phase-2-trial-of-nangibotide-in-covid-19-patients/ 2020-07-24T11:20:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/virus-5410598_640-1.jpg https://www.pharmaceutical-business-review.com/news/novartis-announces-phase-iii-study-of-jakavi-in-chronic-graft-versus-host-disease-met-primary-and-key-secondary-endpoints/ 2020-07-27T00:56:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Novar.jpg https://www.pharmaceutical-business-review.com/news/gileads-kite-tecartus/ 2020-07-27T08:51:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/moderna-announces-expansion-of-barda-agreement-to-support-larger-phase-3-programme-for-covid-19-vaccine/ 2020-07-27T10:18:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Large-vaccine.jpg https://www.pharmaceutical-business-review.com/news/humanetics-gets-financing-from-niaid-to-study-bio-300-drug-in-covid-19-patients/ 2020-07-27T10:39:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Humanetics.jpg https://www.pharmaceutical-business-review.com/news/janssen-gets-chmp-positive-opinion-for-expanded-use-of-imbruvica-rituximab-combo-in-cll/ 2020-07-27T10:44:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/11/Johnson.jpg https://www.pharmaceutical-business-review.com/news/celltrion-secures-ec-approval-for-remsima-sc-for-five-more-indications/ 2020-07-28T10:59:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/1131px-European_Commission_in_Brussels-1.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-bnt162b2-vaccine/ 2020-07-28T11:04:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Biontech-1.jpg https://www.pharmaceutical-business-review.com/news/neoimmunetech-gets-ind-clearance-for-nt-i7-trial-in-locally-recurrent-scchn/ 2020-07-28T11:07:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/cancer-cells-541954_640-7.jpg https://www.pharmaceutical-business-review.com/news/ai-therapeutics-announces-start-of-phase-ii-trial-of-lam-002a-to-treat-covid-19-patients/ 2020-07-28T11:33:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Ai-.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-astrazeneca-ds-1062/ 2020-07-28T11:44:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/AstraZeneca-headquarters-1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-ckd-trial/ 2020-07-29T06:14:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/AstraZeneca-headquarters-2.jpg https://www.pharmaceutical-business-review.com/news/karuna-therapeutics-and-psychogenics-announce-drug-discovery-collaboration/ 2020-07-29T06:19:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/handshake-3298455_640-42.jpg https://www.pharmaceutical-business-review.com/news/nura-bio-launches-to-discover-and-develop-neuroprotective-drug/ 2020-07-30T10:32:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Neuro-bio.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-designation-to-mercks-mk-6482-in-vhl-disease-associated-rcc/ 2020-07-30T10:42:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/roches-tocilizumab-covid-19/ 2020-07-30T10:44:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/CovidRoche.png https://www.pharmaceutical-business-review.com/news/dfc-kodak-pharma-business/ 2020-07-30T10:46:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/kodak_tower.jpg https://www.pharmaceutical-business-review.com/news/sab-biotherapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-of-sab-176-for-seasonal-influenza/ 2020-07-31T11:08:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/SAB.jpg https://www.pharmaceutical-business-review.com/news/tagrisso-granted-fda-breakthrough-therapy-status-in-egfr-mutated-lung-cancer/ 2020-07-31T11:26:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Gaithusberg.jpg https://www.pharmaceutical-business-review.com/news/pfizer-covid-19-vaccine-study/ 2020-08-03T03:08:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-roches-tecentriq-plus-cotellic-and-zelboraf-for-people-with-advanced-melanoma/ 2020-08-03T11:19:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/sanofi-gsk-to-supply-us-govt-with-100-million-doses-of-covid-19-vaccine/ 2020-08-03T11:19:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/coronavirus-5394069_640.jpg https://www.pharmaceutical-business-review.com/news/takeda-pevonedistat-hr-mds/ 2020-08-03T11:23:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Takeda.jpg https://www.pharmaceutical-business-review.com/news/sanofi-epilepsy-drug-depakine/ 2020-08-04T10:24:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Epilepsy.jpg https://www.pharmaceutical-business-review.com/news/abcellera-provides-covid-19-programme-update-with-start-of-phase-3-clinical-trials/ 2020-08-04T11:13:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/coronatrial.jpg https://www.pharmaceutical-business-review.com/news/immunitybio-had5-vaccine-covid-19/ 2020-08-04T11:18:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/coronavirus-disease-covid-2019-5060427_640.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-ind-for-pscs-stem-cell-therapy-candidate-for-covid-19/ 2020-08-04T11:26:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/dna-5297378_640-2.jpg https://www.pharmaceutical-business-review.com/news/myr-pharmaceuticals-receives-conditional-marketing-authorisation-by-european-commission-for-hepcludex/ 2020-08-05T10:41:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Euro.jpg https://www.pharmaceutical-business-review.com/news/rlf-100-phase-2-3-clinical-trial/ 2020-08-05T11:40:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/corona-5401250_640-1.jpg https://www.pharmaceutical-business-review.com/news/seismic-bio-partners-with-twist-bioscience-for-discovery-and-optimisation-of-antibodies/ 2020-08-05T11:44:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/deal-4131445_640-12.jpg https://www.pharmaceutical-business-review.com/news/lorbrena-significantly-improves-progression-free-survival-in-first-line-alk-positive-lung-cancer/ 2020-08-06T10:49:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/jj-announces-agreement-with-us-govt-for-100-million-doses-of-investigational-covid-19-vaccine/ 2020-08-06T10:56:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/03/Johnson.jpg https://www.pharmaceutical-business-review.com/news/gsk-blenrep-multiple-myeloma/ 2020-08-07T09:01:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/GSK-house.jpg https://www.pharmaceutical-business-review.com/news/reviral-sisunatovir-rsv-infection/ 2020-08-07T09:01:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-astrazeneca-collaborate-to-evaluate-patritumab-deruxtecan-in-combination-with-tagrisso-in-egfr-mutated-nsclc/ 2020-08-07T11:01:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/pharmatablet.jpg https://www.pharmaceutical-business-review.com/news/us-fda-approves-lampit-for-the-treatment-of-chagas-disease-in-children/ 2020-08-10T10:39:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/01/Bayer.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-dovato-2/ 2020-08-10T10:40:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Dovato.jpg https://www.pharmaceutical-business-review.com/news/pfizer-announces-agreement-with-gilead-to-manufacture-remdesivir-to-treat-covid-19/ 2020-08-10T10:46:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Gilead.jpg https://www.pharmaceutical-business-review.com/news/remdesivir-simple-trial-results/ 2020-08-11T09:48:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/covid-19-4982910_640-6.jpg https://www.pharmaceutical-business-review.com/news/ligand-pharmaceuticals-pfenex/ 2020-08-11T09:49:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Ligand.jpg https://www.pharmaceutical-business-review.com/news/roche-spinal-muscular-atrophy/ 2020-08-11T09:51:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Roche-office.jpg https://www.pharmaceutical-business-review.com/news/omeros-reports-positive-results-for-narsoplimab-in-treatment-of-covid-19-associated-ards/ 2020-08-11T10:20:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/corona-5174671_640-3.jpg https://www.pharmaceutical-business-review.com/news/fda-clears-appili-therapeutics-to-expand-its-trial-of-favipiravir-for-prrevention-of-covid-19/ 2020-08-11T11:16:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Flavir.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-veklury-nda/ 2020-08-12T15:16:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/virus-4937553_640-2.jpg https://www.pharmaceutical-business-review.com/news/checkmate-577-trial-for-opdivo-meets-primary-endpoint-of-disease-free-survival/ 2020-08-12T15:21:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/moderna-announces-supply-agreement-with-us-government-for-initial-100-million-doses-of-mrna-vaccine-against-covid-19/ 2020-08-12T15:44:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/coronadose.jpg https://www.pharmaceutical-business-review.com/news/bayer-kandy-therapeutics/ 2020-08-13T11:02:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Bayer.jpg https://www.pharmaceutical-business-review.com/news/inpedild-trial-enrols-first-patient-to-evaluate-nintedanib-in-pediatric-population-with-fibrosing-ild/ 2020-08-13T11:08:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/1200px-Siedziba_Boehringer_Ingelheim_w_Polsce.jpg https://www.pharmaceutical-business-review.com/news/blade-therapeutics-updates-enrolment-progress-for-covid-19-pneumonia-study-of-bld-2660/ 2020-08-13T11:17:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Blade.jpg https://www.pharmaceutical-business-review.com/news/genecentric-janssen-nmibc/ 2020-08-14T09:29:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Pharmatablet-1.jpg https://www.pharmaceutical-business-review.com/news/union-therapeutics-to-acquire-licence-for-covid-19-technologies-developed-by-tff-pharmaceuticals/ 2020-08-14T11:56:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Union.jpg https://www.pharmaceutical-business-review.com/news/sanofi-principia-biopharma/ 2020-08-17T09:42:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Sanofi.jpg https://www.pharmaceutical-business-review.com/uncategorized/chugais-enspryng-receives-regulatory-approval-from-fda-for-neuromyelitis-optica-spectrum-disorder/ 2020-08-17T10:13:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-azd1222-vaccine-ec-deal/ 2020-08-17T10:47:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/AstraZeneca-headquarters.jpg https://www.pharmaceutical-business-review.com/news/enzychem-covid-19-pneumonia/ 2020-08-17T10:48:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Enzymate.jpg https://www.pharmaceutical-business-review.com/news/first-hbv-patient-dosed-in-phase-iia-clinical-trial-of-asc22/ 2020-08-17T10:54:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/test-214185_640-11.jpg https://www.pharmaceutical-business-review.com/news/bold-100-significantly-outperforms-remdesivir-head-to-head-in-sars-cov-2-model/ 2020-08-18T10:58:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/bold.jpg https://www.pharmaceutical-business-review.com/news/gni-group-announces-positive-results-from-study-of-f351-as-therapy-for-hbv-related-liver-fibrosis-in-china/ 2020-08-18T11:00:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Liver.png https://www.pharmaceutical-business-review.com/news/gilead-tango-immuno-oncology/ 2020-08-18T12:39:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Gilead-1.jpg https://www.pharmaceutical-business-review.com/news/europes-largest-initiative-launches-to-accelerate-therapy-development-for-covid-19/ 2020-08-19T16:39:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Europe.jpg https://www.pharmaceutical-business-review.com/news/agilent-frederick-facility/ 2020-08-20T08:15:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/nucleic-acid.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-share-positive-early-data-on-mrna-vaccine-candidate-bnt162b2-against-covid-19/ 2020-08-21T10:01:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Covid.jpg https://www.pharmaceutical-business-review.com/news/abcellera-acquires-orthomab-bispecific-platform-from-dualogics/ 2020-08-21T10:53:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/business-4109459_640-2.jpg https://www.pharmaceutical-business-review.com/news/blackstone-takeda-consumer/ 2020-08-24T09:47:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Takeda.jpg https://www.pharmaceutical-business-review.com/news/fda-issues-eua-for-convalescent-plasma-as-potential-promising-covid-19-treatment/ 2020-08-24T10:28:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/novartis-kesimpta-multiple-sclerosis/ 2020-08-24T10:41:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Novartis-1.jpg https://www.pharmaceutical-business-review.com/news/novartis-phase-3-combi-i-trial-fails-to-meet-primary-endpoint/ 2020-08-24T10:54:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/tower-with-logo-through-branches-image.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-forbius/ 2020-08-25T08:54:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Bristol-Myers-Squibb-1.jpg https://www.pharmaceutical-business-review.com/news/exelixis-announces-submission-of-snda-to-fda-for-cabometyx-plus-opdivo-for-advanced-rcc/ 2020-08-25T10:09:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/catalent-azd1222-manufacturing-us/ 2020-08-25T11:09:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/syringe-417786_640-2.jpg https://www.pharmaceutical-business-review.com/news/odonate-announces-positive-top-line-results-for-tesetaxel-in-phase-3-metastatic-breast-cancer-trial/ 2020-08-25T11:19:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/science-1336663_640-5.jpg https://www.pharmaceutical-business-review.com/news/acadia-cersci-therapeutics/ 2020-08-26T09:46:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Acadia.jpg https://www.pharmaceutical-business-review.com/news/sinovac-signs-agreement-with-bio-farma-indonesia-for-covi-19-vaccine-cooperation/ 2020-08-26T10:44:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Sino.jpg https://www.pharmaceutical-business-review.com/news/gsk-blenrep-multiple-myeloma-2/ 2020-08-27T08:40:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/GSK-house-1.jpg https://www.pharmaceutical-business-review.com/news/hifibio-submits-ind-application-for-sars-cov-2-neutralising-antibody-to-treat-covid-19-patients/ 2020-08-27T09:30:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Hibibo.jpg https://www.pharmaceutical-business-review.com/news/rocket-pharmaceuticals-receives-fda-fast-track-designation-for-rp-l401-gene-therapy-for-infantile-malignant-osteopetrosis/ 2020-08-28T10:45:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/FDA-drug-5.jpg https://www.pharmaceutical-business-review.com/news/beigene-singlomics-covid-19/ 2020-08-31T10:48:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Begine.jpg https://www.pharmaceutical-business-review.com/news/celltrion-receives-korean-mfds-approval-to-initiate-trial-of-covid-19-antiviral-antibody-treatment-candidate/ 2020-08-31T11:07:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Korea.png https://www.pharmaceutical-business-review.com/news/gilead-veklury-covid-19/ 2020-08-31T11:13:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Gilead-2.jpg https://www.pharmaceutical-business-review.com/news/ionis-akcea-therapeutics/ 2020-09-01T09:58:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Ionis.jpg https://www.pharmaceutical-business-review.com/news/orpheris-enrols-first-patients-in-phase-2-clinical-study-evaluating-op-101-for-severe-covid-19/ 2020-09-01T10:05:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/orpheris.jpg https://www.pharmaceutical-business-review.com/news/clear-creek-bio-brequinar/ 2020-09-02T08:24:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/cleat-creek.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-onureg-as-continued-treatment-for-adults-in-first-remission-with-aml/ 2020-09-02T10:06:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/twist-bioscience-announces-potent-sars-cov-2-neutralising-data-from-covid-19-therapeutic-antibody-programme/ 2020-09-03T10:43:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/twist.jpg https://www.pharmaceutical-business-review.com/news/sanofi-gsk-covid-19-vaccine/ 2020-09-04T09:33:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/GScorona.jpg https://www.pharmaceutical-business-review.com/news/kite-hifibio-therapeutics-partner-to-discover-novel-targets-and-antibodies-against-aml/ 2020-09-04T10:30:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/AML.jpg https://www.pharmaceutical-business-review.com/news/roche-gavreto-nsclc/ 2020-09-07T08:52:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Roche-office.jpg https://www.pharmaceutical-business-review.com/news/ampio-announces-enrolment-completion-for-intravenous-covid-19-clinical-trial/ 2020-09-07T09:59:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Avacto.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-trulicity/ 2020-09-07T10:41:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Elil-Liil.jpg https://www.pharmaceutical-business-review.com/news/janssen-imbruvica-rituximab/ 2020-09-08T08:37:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/ECbuild.jpg https://www.pharmaceutical-business-review.com/news/ascentage-pharmas-bcl-2-inhibitor-apg-2575-granted-orphan-drug-designation-by-fda-to-treat-chronic-lymphocytic-leukaemia/ 2020-09-08T10:32:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/exelixis-nbe-join-forces-for-discovery-and-development-of-adcs-for-cancer/ 2020-09-09T11:08:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/cancer-cells-541954_640-9.jpg https://www.pharmaceutical-business-review.com/news/takeda-divests-select-non-core-assets-in-europe-to-cheplapharm-for-approximately-562m/ 2020-09-09T11:25:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Takeda.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-to-supply-eu-with-200-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2/ 2020-09-10T10:50:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Pfize.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-trelegy-ellipta-as-once-daily-single-inhaler-triple-therapy-for-asthma-and-copd/ 2020-09-10T13:09:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/cycle-pharmaceuticals-secures-25m-debt-financing/ 2020-09-10T13:12:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/office-1209640_640-25.jpg https://www.pharmaceutical-business-review.com/news/bayer-adempas-phase-4-trial/ 2020-09-10T13:14:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Bayer-headquarters.jpg https://www.pharmaceutical-business-review.com/news/novartis-says-high-dose-enerzair-breezhaler-reduces-asthma-exacerbations-versus-medium-dose/ 2020-09-10T13:16:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/novartis-building-pnd.jpg https://www.pharmaceutical-business-review.com/news/grifols-alkahest-full-ownership/ 2020-09-10T13:18:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/job-4131482_640-30.jpg https://www.pharmaceutical-business-review.com/news/octapharma-launches-phase-3-superiority-study-for-pans/ 2020-09-10T13:19:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/lab-3498584_640-4.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-azd7442-phase-1-trial/ 2020-09-10T15:20:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/AstraZeneca-headquarters-1.jpg https://www.pharmaceutical-business-review.com/news/engitix-signs-collaboration-and-licensing-agreement-with-takeda-to-develop-anti-fibrotic-therapies-in-advanced-liver-diseases/ 2020-09-10T15:21:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/05/Takeda.jpg https://www.pharmaceutical-business-review.com/news/novartis-abl001-meets-primary-endpoint-of-phase-3-chronic-myeloid-leukemia-study/ 2020-09-10T15:21:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/novartis-building-pnd.jpg https://www.pharmaceutical-business-review.com/news/treadwell-initiates-expansion-of-cohorts-in-phase-1-study-of-cfi-402257/ 2020-09-10T15:22:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/lab-3498584_640-3.jpg https://www.pharmaceutical-business-review.com/news/fsd-pharma-fsd201-phase-2-trial-fda/ 2020-09-10T15:24:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/corona-5174671_640-4.jpg https://www.pharmaceutical-business-review.com/news/farxiga-significantly-reduces-kidney-failure-and-cv-or-renal-death-risks-in-ckd-patients-in-dapa-ckd-trial/ 2020-09-10T15:25:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/04/Astra.jpg https://www.pharmaceutical-business-review.com/news/vir-gsk-vir-7831-phase-2-3-trial/ 2020-09-10T15:26:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/injecting-519389_640.jpg https://www.pharmaceutical-business-review.com/news/omeros-investigational-new-drug-application-for-oms906-cleared-by-fda/ 2020-09-10T15:27:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/gilead-jounce-therapeutics-licensing-deal/ 2020-09-10T15:28:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/cancer-cells-541954_640-8.jpg https://www.pharmaceutical-business-review.com/news/imfinzi-approved-in-the-eu-for-the-treatment-of-extensive-stage-small-cell-lung-cancer/ 2020-09-10T15:30:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Gaithusberg.jpg https://www.pharmaceutical-business-review.com/news/pharmacyte-biotech-submits-ind-to-fda-for-clinical-trial-in-inoperable-pancreatic-cancer/ 2020-09-10T15:30:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/science-1336663_640-6.jpg https://www.pharmaceutical-business-review.com/news/mylan-aspen-thrombosis/ 2020-09-10T16:14:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/aspen.jpg https://www.pharmaceutical-business-review.com/news/sab-185-phase-1b-trial-covid-19/ 2020-09-10T17:58:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/coronavirus-4972480_640-14.jpg https://www.pharmaceutical-business-review.com/news/biolinerx-achieves-enrolment-target-in-phase-3-genesis-trial-for-planned-interim-analysis/ 2020-09-10T18:00:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/science-1336663_640-4.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-momenta-pharmaceuticals/ 2020-09-10T18:01:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Johnson-Johnson-headquarters.jpg https://www.pharmaceutical-business-review.com/news/imfinzi-granted-fda-priority-review-for-less-frequent-fixed-dose-use/ 2020-09-10T18:02:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/lilly-innovent-tyvyt-licensing-deal/ 2020-09-10T18:03:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Lilly-corporate-center.jpg https://www.pharmaceutical-business-review.com/news/bms-dragonfly-therapeutics-il-12/ 2020-09-10T18:03:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Bristol-Myers-Squibb.jpg https://www.pharmaceutical-business-review.com/news/sab-biotherapeutics-sab-185-phase-1-trial/ 2020-09-10T18:06:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/covid-19-4907621_640-1.jpg https://www.pharmaceutical-business-review.com/news/novavax-takeda-nvx%e2%80%91cov2373/ 2020-09-10T18:07:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/1200px-Takeda_Pharmaceutical_Company_Tokyo_Head_Office_1.jpg https://www.pharmaceutical-business-review.com/news/france-eye-drug-practices-novartis-roche/ 2020-09-11T09:16:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/eye.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-pauses-azd1222-covid-19-trial/ 2020-09-11T09:16:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/AstraZeneca-headquarters.jpg https://www.pharmaceutical-business-review.com/news/terns-pharmaceuticals-receives-fast-track-designation-for-tern-201-as-a-treatment-for-nash/ 2020-09-11T11:20:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-dupixent/ 2020-09-14T10:23:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/axons-covid-19-vaccine/ 2020-09-14T10:23:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Axon-trial.jpg https://www.pharmaceutical-business-review.com/news/covid-19-vaccine-azd1222-clinical-trials-resumed-in-the-uk/ 2020-09-14T10:26:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/AstraZeneca-headquarters.jpg https://www.pharmaceutical-business-review.com/news/pfizer-and-biontech-propose-expansion-of-pivotal-covid-19-vaccine-trial/ 2020-09-14T11:32:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/covid-19.jpg https://www.pharmaceutical-business-review.com/news/merck-seattle-genetics/ 2020-09-15T09:40:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Merck.jpg https://www.pharmaceutical-business-review.com/news/baricitinib-plus-remdesivir-reduces-time-to-recovery-in-covid-19-patients-in-niaid-sponsored-actt-2-trial/ 2020-09-15T10:23:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/cor-virus.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-acquire-immunomedics/ 2020-09-15T10:47:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/job-4131482_640-31.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-initiates-phase-2-study-of-patritumab-deruxtecan-in-advanced-colorectal-cancer/ 2020-09-15T10:52:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/test-214185_640-12.jpg https://www.pharmaceutical-business-review.com/news/takeda-cell-therapy/ 2020-09-16T08:47:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Tak.jpg https://www.pharmaceutical-business-review.com/news/melior-pharmaceuticals-awarded-grant-for-advancing-pulmonary-therapeutic-in-covid-19-phase-2-clinical-trial/ 2020-09-16T09:04:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Meru.jpg https://www.pharmaceutical-business-review.com/news/hifibio-abl-bio-hfb30132a-covid-19/ 2020-09-16T10:55:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/covid-19-4982910_640-11.jpg https://www.pharmaceutical-business-review.com/news/curasen-doses-first-subjects-in-phase-1-trial-of-cst-2032/ 2020-09-16T11:03:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/blood-20745_640-2.jpg https://www.pharmaceutical-business-review.com/news/moderna-chiesi-collaborate-to-develop-mrna-therapeutics-for-pulmonary-arterial-hypertension/ 2020-09-17T10:54:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/drug.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-rdif-sputnik/ 2020-09-18T05:36:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/sputnik.jpg https://www.pharmaceutical-business-review.com/news/gilead-magrolimab-mds-fda-breakthrough/ 2020-09-18T05:36:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/cancer-cells-541954_640-11.jpg https://www.pharmaceutical-business-review.com/news/santen-and-us-ophthalmic-company-eyevance-enter-into-share-purchase-agreement/ 2020-09-18T05:42:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/hands-1445472_640-4.jpg https://www.pharmaceutical-business-review.com/news/sanofi-gsk-covid-19/ 2020-09-21T09:35:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Sanvaccine.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-pcsk9-dogma-therapeutics/ 2020-09-21T10:42:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/AstraZeneca-headquarters.jpg https://www.pharmaceutical-business-review.com/news/vifor-pharma-group-announces-successful-sale-of-om-pharma/ 2020-09-21T10:42:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/om-pharma.jpg https://www.pharmaceutical-business-review.com/news/merck-reports-new-positive-outcomes-for-keytruda-in-stage-3-melanoma-trial/ 2020-09-21T10:47:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/roche-inflazome/ 2020-09-22T09:13:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Roche.jpg https://www.pharmaceutical-business-review.com/news/onkure-pfizer-collaborate-to-evaluate-combination-of-oki-179-and-binimetinib/ 2020-09-22T10:20:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Pfize-1.jpg https://www.pharmaceutical-business-review.com/news/padcev-phase-3-trial-urothelial-cancer/ 2020-09-22T10:22:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Padcev_20mg.jpg https://www.pharmaceutical-business-review.com/news/mercks-keytruda-plus-chemotherapy-meets-os-and-pfs-goals-in-keynote-590-trial/ 2020-09-22T10:28:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/sanofi-gsk-sign-agreements-with-government-of-canada-to-supply-72-million-doses-of-adjuvanted-covid-19-vaccine/ 2020-09-23T10:14:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/GSK.jpg https://www.pharmaceutical-business-review.com/news/bms-opdivo-checkmate-649-trial/ 2020-09-23T10:46:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Bristol-Myers-Squibb.jpg https://www.pharmaceutical-business-review.com/news/micreos-initiates-clinical-trial-to-evaluate-endolysin-drug-in-atopic-dermatitis/ 2020-09-23T10:51:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/endolysin-scaled.jpg https://www.pharmaceutical-business-review.com/news/sinovac-covid-19-turkey/ 2020-09-24T06:10:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Sinovac.jpg https://www.pharmaceutical-business-review.com/news/bms-bluebird-fda-priority-review-ide-cel/ 2020-09-24T06:10:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/dna-5297378_640-3.jpg https://www.pharmaceutical-business-review.com/news/permira-funds-to-acquire-european-cns-specialty-pharmaceutical-company-neuraxpharm/ 2020-09-24T06:15:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/news_crop_neuraxpharm-building.jpg https://www.pharmaceutical-business-review.com/news/oncoimmune-saccovid-covid-19/ 2020-09-25T08:41:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Oncoimmune.jpg https://www.pharmaceutical-business-review.com/news/anokion-announces-fda-clearance-of-ind-application-for-ank-700-to-treat-multiple-sclerosis/ 2020-09-25T10:52:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/millendo-therapeutics-initiates-first-in-human-clinical-trial-of-mle-301/ 2020-09-25T11:01:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/test-214185_640-13.jpg https://www.pharmaceutical-business-review.com/news/arena-doses-first-subject-in-elevate-uc-12-phase-3-trial-of-etrasimod-in-ulcerative-colitis/ 2020-09-28T10:49:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/lab-3498584_640-5.jpg https://www.pharmaceutical-business-review.com/news/ec-grants-marketing-authorisation-for-jyseleca-to-treat-adults-with-moderate-to-severe-active-rheumatoid-arthritis/ 2020-09-28T11:22:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/EC.jpg https://www.pharmaceutical-business-review.com/news/jj-gram-covid-19/ 2020-09-28T12:00:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/John.jpg https://www.pharmaceutical-business-review.com/news/avrobio-receives-orphan-drug-designation-from-european-medicines-agency-for-avr-rd-02/ 2020-09-29T10:24:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Euro.jpg https://www.pharmaceutical-business-review.com/news/viiv-begins-implementation-science-study-for-hiv-treatment-regimen-candidate-in-europe/ 2020-09-29T10:31:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/syringe-4544448_640.jpg https://www.pharmaceutical-business-review.com/news/inovio-covid-19-vaccine/ 2020-09-29T11:28:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Inovia.jpg https://www.pharmaceutical-business-review.com/news/gsk-nucala-hypereosinophilic/ 2020-09-29T11:29:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/GSK-house.jpg https://www.pharmaceutical-business-review.com/news/kuur-therapeutics-announces-first-patients-dosed-with-allogeneic-car-nkt-cell-therapy/ 2020-09-30T11:42:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/test-214185_640-14.jpg https://www.pharmaceutical-business-review.com/news/infinity-receives-fast-track-designation-for-eganelisib-in-combination-with-checkpoint-inhibitor-and-chemotherapy-for-advanced-tnbc/ 2020-09-30T11:45:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/FDA-drug-5.jpg https://www.pharmaceutical-business-review.com/news/orgenesis-koligo-therapeutics/ 2020-09-30T12:04:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/adam.jpg https://www.pharmaceutical-business-review.com/news/pfizer-gets-fda-nod-for-xeljanz-to-treat-juvenile-idiopathic-arthritis/ 2020-09-30T12:05:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/medincell-covid-19-ivermectin/ 2020-10-01T07:38:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Pix.jpg https://www.pharmaceutical-business-review.com/news/baylx-receives-us-fda-clearance-of-covid-19-ind-application-for-umbilical-cord-tissue-mesenchymal-stem-cells-product/ 2020-10-01T10:36:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/alnylam-reports-positive-results-from-illuminate-b-phase-3-study-of-lumasiran/ 2020-10-01T11:29:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/science-1336663_640-7.jpg https://www.pharmaceutical-business-review.com/news/covis-group-amag-pharmaceuticals/ 2020-10-05T07:31:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Amag.jpg https://www.pharmaceutical-business-review.com/news/pfizer-cstone-pharmaceuticals/ 2020-10-05T07:31:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-opdivo-yervoy-combo-for-previously-untreated-unresectable-mpm/ 2020-10-05T11:27:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/BMSbuild.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-glycomimetics-rare-paediatric-disease-designation-for-rivipansel-for-treatment-of-sickle-cell-disease/ 2020-10-06T10:59:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/immunogen-imgn632-bpdcn/ 2020-10-06T11:12:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-fda-btd-ckd/ 2020-10-06T11:14:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/AstraZeneca-headquarters.jpg https://www.pharmaceutical-business-review.com/news/eureka-initiates-trial-to-evaluate-et140203-artemis-t-cell-therapy-in-hcc/ 2020-10-06T11:19:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/cancer-cells-541954_640-12.jpg https://www.pharmaceutical-business-review.com/news/biontech-pfizer-initiate-rolling-submission-to-ema-for-sars-cov-2-vaccine-candidate/ 2020-10-07T11:17:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Biontech.jpg https://www.pharmaceutical-business-review.com/news/scribe-therapeutics-biogen-crispr/ 2020-10-07T11:20:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Crisper.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-myokardia/ 2020-10-07T11:21:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/BMS-facility.jpg https://www.pharmaceutical-business-review.com/news/fda-broadly-supports-oragenics-pre-ind-development-programme-for-sars-cov-2-vaccine/ 2020-10-07T11:33:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/gsk-vir-biotechnology-covid-19/ 2020-10-08T07:09:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Vir.jpg https://www.pharmaceutical-business-review.com/news/pfizer-sangamo-dose-first-participant-in-phase-3-study-of-hemophilia-a-gene-therapy-treatment/ 2020-10-08T11:14:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/noxopharm-announces-first-covid-19-patient-treated-in-veyonda-study/ 2020-10-09T11:12:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Nexo.jpg https://www.pharmaceutical-business-review.com/news/ocular-therapeutix-announces-topline-phase-1-clinical-trial-results-of-otx-csi/ 2020-10-12T01:43:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Oculo.jpg https://www.pharmaceutical-business-review.com/news/arca-fda-ind-approval-ab201/ 2020-10-12T11:11:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/virus-4937553_640-3.jpg https://www.pharmaceutical-business-review.com/news/gannex-received-us-ind-approval-for-its-nash-drug-candidate-asc42/ 2020-10-12T11:54:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/bms-presents-positive-data-from-phase-3-true-north-trial-of-zeposia-in-uc/ 2020-10-12T12:03:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-covid-19/ 2020-10-12T14:18:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/JandJ.jpg https://www.pharmaceutical-business-review.com/news/phase-3-trial-jnj-78436735-covid-19/ 2020-10-13T06:12:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/Johnson-Johnson-headquarters.jpg https://www.pharmaceutical-business-review.com/news/pfizer-ibrance-breast-cancer/ 2020-10-13T09:29:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/rigel-covid-19-trial-with-fostamatinib/ 2020-10-13T09:30:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Rigel.jpg https://www.pharmaceutical-business-review.com/news/hitgen-to-acquire-fragment-and-structure-based-biotech-company-vernalis/ 2020-10-13T09:35:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Structture.jpg https://www.pharmaceutical-business-review.com/news/seagen-astellas-report-positive-results-from-padcev-phase-2-trial-in-advanced-urothelial-cancer/ 2020-10-13T11:00:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/test-214185_640-15.jpg https://www.pharmaceutical-business-review.com/news/world-bank-12bn-package-covid-19-vaccines/ 2020-10-15T07:48:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/1112px-World_Bank_building_at_Washington-1.jpg https://www.pharmaceutical-business-review.com/news/jj-covid-19-vaccine/ 2020-10-15T07:48:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/JanJ.jpg https://www.pharmaceutical-business-review.com/news/moderna-secures-eligibility-for-submission-of-maa-of-mrna-1273-to-ema/ 2020-10-15T11:33:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/syringe-417786_640-3.jpg https://www.pharmaceutical-business-review.com/news/y-mabs-announces-fda-clearance-of-ind-for-its-lutetium-177-labelled-omburtamab-antibody/ 2020-10-15T11:38:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/cancer-cells-541954_640-13.jpg https://www.pharmaceutical-business-review.com/news/immunitybio-covid-19-vaccine/ 2020-10-16T10:53:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Hd5.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-expanded-indication-for-mercks-keytruda-in-adult-patients-with-relapsed-or-refractory-chl/ 2020-10-16T10:54:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/sanofi-translate-bio-mrna-covid-19-vaccine-candidate-induced-high-antibody-levels-in-preclinical-studies/ 2020-10-16T11:27:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/covid-19-4982910_640-13.jpg https://www.pharmaceutical-business-review.com/news/regeneron-inmazeb-fda-approval-ebola/ 2020-10-18T14:16:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Regeneron-headquarters.jpg https://www.pharmaceutical-business-review.com/news/genentech-announces-full-fda-approval-for-venclexta-combinations-for-acute-myeloid-leukemia/ 2020-10-19T11:15:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-5.jpg https://www.pharmaceutical-business-review.com/news/dren-bio-announces-a-60m-series-a-financing/ 2020-10-19T11:59:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/job-4131482_640-35.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-rdif-sputnik-v/ 2020-10-20T09:23:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Sputnik.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-disarm-therapeutics/ 2020-10-20T09:23:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/lilly.jpg https://www.pharmaceutical-business-review.com/news/versantis-receives-fda-rare-paediatric-disease-designation-for-vs-01-to-treat-urea-cycle-disorders/ 2020-10-20T11:10:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-6.jpg https://www.pharmaceutical-business-review.com/news/velosbio-announces-first-patient-dosed-in-phase-2-trial-of-vls-101-in-solid-tumours/ 2020-10-20T11:48:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/test-214185_640-16.jpg https://www.pharmaceutical-business-review.com/news/xeris-pharmaceuticals-granted-fast-track-designation-by-fda-for-novel-concentrated-diazepam-formulation-for-injection/ 2020-10-21T10:24:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-8.jpg https://www.pharmaceutical-business-review.com/news/jsr-life-sciences-biologics/ 2020-10-21T10:42:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/drug-substance.jpg https://www.pharmaceutical-business-review.com/news/vifor-pharma-cara-therapeutics/ 2020-10-21T10:43:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Human-kidney.jpg https://www.pharmaceutical-business-review.com/news/tagrisso-granted-fda-priority-review-in-early-stage-egfr-mutated-lung-cancer/ 2020-10-21T12:08:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/06/Gaithusberg.jpg https://www.pharmaceutical-business-review.com/news/effrx-pharmaceuticals-signs-exclusive-license-agreement-with-diurnal-for-registration-and-commercialisation-of-alkindi/ 2020-10-22T12:03:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Tablt.jpg https://www.pharmaceutical-business-review.com/news/novartis-gets-fda-orphan-drug-status-for-branaplam-to-treat-huntingtons-disease/ 2020-10-22T12:03:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Novartis.jpg https://www.pharmaceutical-business-review.com/news/astellas-pharma-primary-mitochondrial/ 2020-10-22T12:04:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-7.jpg https://www.pharmaceutical-business-review.com/news/gilead-announces-new-data-on-biktarvy-for-the-treatment-of-hiv-in-black-americans/ 2020-10-22T12:04:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/science-1336663_640-8.jpg https://www.pharmaceutical-business-review.com/news/immunitybio-nantkwest-covid-19/ 2020-10-23T06:17:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Cor.jpg https://www.pharmaceutical-business-review.com/news/sirnaomics-seals-105m-series-d-financing-for-rnai-therapeutics/ 2020-10-23T11:29:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/paper-3213924_640-4.jpg https://www.pharmaceutical-business-review.com/news/fda-gilead-veklury-covid-19-approval/ 2020-10-26T07:58:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/1200px-FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/fda-authorises-restart-of-the-covid-19-azd1222-vaccine-us-phase-3-trial/ 2020-10-26T11:21:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/moderna-to-supply-qatar-with-mrna-vaccine-against-covid-19/ 2020-10-27T10:51:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Qatar.jpg https://www.pharmaceutical-business-review.com/news/hifibio-completes-first-cohort-of-phase-1-study-of-sars-cov-2-neutralising-antibody/ 2020-10-27T11:41:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/coronavirus-4972480_640-15.jpg https://www.pharmaceutical-business-review.com/news/novartis-iptacopan-ema-orphan-drug-designation-igan/ 2020-10-28T02:40:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/novartis-building-pnd.jpg https://www.pharmaceutical-business-review.com/news/ana-therapeutics-oral-niclosamide/ 2020-10-28T05:10:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/trial.jpg https://www.pharmaceutical-business-review.com/news/aurinia-voclosporin-covid-19/ 2020-10-28T07:59:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Volarin.jpg https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-announces-fda-approval-of-eysuvis-for-short-term-treatment-of-dry-eye-disease/ 2020-10-28T10:56:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-9.jpg https://www.pharmaceutical-business-review.com/news/bayer-asklepios-biopharmaceutical/ 2020-10-28T11:11:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Bioreactor.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-and-ema-accepts-regulatory-submission-for-pfizers-abrocitinib/ 2020-10-28T11:49:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/novartis-collaborates-with-molecular-partners-to-develop-two-darpin-therapies-designed-for-covid-19/ 2020-10-29T10:44:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Novar.jpg https://www.pharmaceutical-business-review.com/news/gsk-sanofi-covid-19-2/ 2020-10-29T10:53:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/COVAX.jpg https://www.pharmaceutical-business-review.com/news/enhertu-gets-fda-priority-review-in-her2-positive-metastatic-gastric-cancer/ 2020-10-29T11:49:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-9.jpg https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-paediatric-psoriasis/ 2020-10-30T07:52:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/08/Novartis.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-antibody-bamlanivimab/ 2020-10-30T08:18:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Lilly-1.jpg https://www.pharmaceutical-business-review.com/news/humanigen-announces-first-patient-dosed-in-nih-activ-5-big-effect-trial-evaluating-lenzilumab-for-covid-19/ 2020-10-30T10:22:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Big-Effect.png https://www.pharmaceutical-business-review.com/news/ec-approves-zejula-as-first-line-monotherapy-maintenance-treatment-in-advanced-ovarian-cancer/ 2020-10-30T11:16:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/701px-GlaxoSmithKline_building_London_30_July_2007_cropped.jpg https://www.pharmaceutical-business-review.com/news/humanigen-announces-first-patient-dosed-in-phase-3-clinical-study-of-lenzilumab-in-covid-19/ 2020-11-02T10:35:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Upjon.jpg https://www.pharmaceutical-business-review.com/news/novartis-adakveo-pain-crises/ 2020-11-02T12:00:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Novarbuilding.jpg https://www.pharmaceutical-business-review.com/news/novartis-vedere-bio/ 2020-11-02T12:02:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Novartis-1.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-insitro/ 2020-11-02T12:02:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/BMs.jpg https://www.pharmaceutical-business-review.com/news/mylan-and-pfizer-receive-ftc-clearance-for-mylan-upjohn-merger/ 2020-11-02T12:07:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/sanofi-offers-to-acquire-clinical-stage-company-kiadis/ 2020-11-03T11:34:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/San.jpg https://www.pharmaceutical-business-review.com/news/cepi-clover-covid-19/ 2020-11-03T11:44:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Clover.jpg https://www.pharmaceutical-business-review.com/news/cheplapharm-astrazeneca/ 2020-11-03T11:44:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Astradeal.jpg https://www.pharmaceutical-business-review.com/news/neuraly-gets-fda-clearance-of-inda-to-initiate-phase-2b-trial-of-nly01-in-alzheimers-disease/ 2020-11-03T12:11:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/10/FDA-drug-9.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbs-deucravacitinib/ 2020-11-04T08:34:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/BMSfacility.jpg https://www.pharmaceutical-business-review.com/news/ionis-and-akcea-announce-that-pfizer-initiated-clinical-study-of-vupanorsen/ 2020-11-04T11:12:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/perkinelmer-horizon-discovery/ 2020-11-04T11:30:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Horizon.jpg https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-initiates-phase-3-study-of-nabiximols-for-multiple-sclerosis-associated-spasticity/ 2020-11-04T11:32:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/test-214185_640-17.jpg https://www.pharmaceutical-business-review.com/news/xnk-therapeutics-receives-us-orphan-drug-status-for-nk-cell-based-immunotherapy-in-multiple-myeloma/ 2020-11-05T10:24:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/nanology-enrols-first-patient-in-phase-2-trial-of-nanopac-for-intratumoral-treatment-of-prostate-cancer/ 2020-11-05T11:38:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/science-1336663_640-9.jpg https://www.pharmaceutical-business-review.com/news/acg-india-iqgen-x/ 2020-11-06T08:09:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/ACG.jpg https://www.pharmaceutical-business-review.com/news/tff-pharmaceuticals-felix-biotechnology-sign-loi-for-collaboration-development-and-licence-agreement/ 2020-11-06T09:57:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Drypowder.jpg https://www.pharmaceutical-business-review.com/news/merck-velosbio/ 2020-11-09T09:40:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Merck.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-gets-eu-approval-for-heart-failure-drug-forxiga/ 2020-11-09T09:40:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Heart-drug.jpg https://www.pharmaceutical-business-review.com/news/pharmaron-acquires-absorption-systems-in-us/ 2020-11-09T10:34:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/CRO.jpg https://www.pharmaceutical-business-review.com/news/bms-gets-ec-approval-for-opdivo-yervoy-combo-for-treatment-of-metastatic-nsclc/ 2020-11-09T12:07:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-us-govt/ 2020-11-10T09:10:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/07/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/sedor-pharmaceuticals-gets-fda-approval-for-sesquient-to-treat-status-epilepticus/ 2020-11-10T11:57:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-gets-fda-eua-status-for-bamlanivimab-to-treat-covid-19/ 2020-11-10T12:06:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Eli-.jpg https://www.pharmaceutical-business-review.com/news/novartis-canakinumab/ 2020-11-10T12:07:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Novar.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-says-cabotegravir-is-superior-to-oral-standard-of-care-for-hiv-prevention-in-women/ 2020-11-10T12:14:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/science-1336663_640-10.jpg https://www.pharmaceutical-business-review.com/news/immunitybio-nantkwest-announce-positive-interim-phase-1-safety-data-of-had5-covid-19-vaccine-dose-study/ 2020-11-11T11:29:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Immune-bio.jpg